{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:08:49Z","timestamp":1784102929863,"version":"3.55.0"},"reference-count":292,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04656-w","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:08:35Z","timestamp":1784099315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Smart nanoparticle vaccines integrate nanotechnology artificial intelligence and immunoengineering for precision immunization"],"prefix":"10.1186","volume":"21","author":[{"given":"Iman","family":"Morshedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Roodaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Gheibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Jaberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JaafarAlsadeq","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shams","family":"Chaloob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Teymourzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"KarkonShayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"4656_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2024.100081","volume":"2","author":"SK Ahmed","year":"2024","unstructured":"Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmood KA, et al. Antimicrobial resistance: impacts, challenges, and future prospects. J Medicine, Surgery, Public Health. 2024;2:100081.","journal-title":"J Medicine, Surgery, Public Health"},{"issue":"4","key":"4656_CR2","first-page":"298","volume":"25","author":"N Satarzadeh","year":"2025","unstructured":"Satarzadeh N, Saraee A, Hatif Mahdi Z, Sadeghi Dousari A, Armanpour M, Taati Moghadam M. Mechanisms in colistin-resistant superbugs transmissible from veterinary, livestock and animal food products to humans. Iran J Vet Res. 2025;25(4):298\u2013311.","journal-title":"Iran J Vet Res"},{"issue":"6","key":"4656_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bsheal.2024.10.001","volume":"6","author":"Y Guo","year":"2024","unstructured":"Guo Y, Gu K, Garber PA, Zhang R, Zhao Z, Xu L. A comparative analysis of influenza and COVID-19: environmental-ecological impacts, socioeconomic implications, and future challenges. Biosaf Health. 2024;6(6):369\u201375.","journal-title":"Biosaf Health"},{"key":"4656_CR4","doi-asserted-by":"crossref","unstructured":"Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, et al. Antimicrobial resistance: a growing serious threat for global public health. Healthcare (Basel). 2023;11(13).","DOI":"10.3390\/healthcare11131946"},{"key":"4656_CR5","doi-asserted-by":"crossref","unstructured":"Ashraf MV, Pant S, Khan MAH, Shah AA, Siddiqui S, Jeridi M, et al. Phytochemicals as antimicrobials: prospecting Himalayan Medicinal plants as source of alternate medicine to combat antimicrobial resistance. Pharmaceuticals (Basel). 2023;16(6).","DOI":"10.3390\/ph16060881"},{"key":"4656_CR6","doi-asserted-by":"crossref","unstructured":"Singh G, Rana A, Smriti. Decoding antimicrobial resistance: unraveling molecular mechanisms and targeted strategies. Arch Microbiol. 2024;206(6):280.","DOI":"10.1007\/s00203-024-03998-2"},{"key":"4656_CR7","doi-asserted-by":"crossref","unstructured":"Mun Y, Hwang JS, Shin YJ. Role of Neutrophils on the Ocular Surface. Int J Mol Sci. 2021;22(19).","DOI":"10.3390\/ijms221910386"},{"issue":"1","key":"4656_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2015.8","volume":"16","author":"X Cao","year":"2016","unstructured":"Cao X. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol. 2016;16(1):35\u201350.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4656_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12016-019-08740-1","volume":"58","author":"S Hillion","year":"2020","unstructured":"Hillion S, Arleevskaya MI, Blanco P, Bordron A, Brooks WH, Cesbron JY, et al. The innate part of the adaptive immune system. Clin Rev Allergy Immunol. 2020;58(2):151\u20134.","journal-title":"Clin Rev Allergy Immunol"},{"key":"4656_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114829","volume":"254","author":"AG Niculescu","year":"2025","unstructured":"Niculescu AG, Dumitrascu AM, Kocer AT, Arayici PP, Yuka SA, Kocer S, et al. Nanotechnology-driven enhancement and modulation of immune responses in monkeypox and respiratory syncytial virus nanovaccine research. Colloids Surf B Biointerfaces. 2025;254:114829.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4656_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-1-0716-1892-9_16","volume":"2412","author":"P Koirala","year":"2022","unstructured":"Koirala P, Bashiri S, Toth I, Skwarczynski M. Current Prospects in peptide-based subunit nanovaccines. Methods Mol Biol. 2022;2412:309\u201338.","journal-title":"Methods Mol Biol"},{"issue":"20","key":"4656_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400323","volume":"13","author":"V Godakhindi","year":"2024","unstructured":"Godakhindi V, Tarannum M, Dam SK, Vivero-Escoto JL. Mesoporous silica nanoparticles as an ideal platform for cancer immunotherapy: recent advances and future directions. Adv Healthc Mater. 2024;13(20):e2400323.","journal-title":"Adv Healthc Mater"},{"key":"4656_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122998","volume":"316","author":"J Xia","year":"2025","unstructured":"Xia J, Chen X, Dong M, Liu S, Zhang L, Pan J, et al. Antigen self-presenting dendrosomes swallowing nanovaccines boost antigens and STING agonists codelivery for cancer immunotherapy. Biomaterials. 2025;316:122998.","journal-title":"Biomaterials"},{"key":"4656_CR14","doi-asserted-by":"crossref","unstructured":"Karaliota S, Moussa M, Rosati M, Devasundaram S, Sengupta S, Goldfarbmuren KC, et al. Highly immunogenic DNA\/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaques. iScience. 2025 28(4):112232.","DOI":"10.1016\/j.isci.2025.112232"},{"key":"4656_CR15","doi-asserted-by":"crossref","unstructured":"Montero DA, Vidal RM, Velasco J, Carre\u00f1o LJ, Torres JP, Benachi O. MA, et al. Two centuries of vaccination: historical and conceptual approach and future perspectives. Frontiers in Public Health. 2024 Volume 11 - 2023.","DOI":"10.3389\/fpubh.2023.1326154"},{"issue":"9","key":"4656_CR16","volume":"16","author":"P Mary Vaishali","year":"2024","unstructured":"Mary Vaishali P, Boopathy N. Edward Jenner: the pioneer of vaccination and his enduring legacy in modern medicine. Cureus. 2024;16(9):e68805.","journal-title":"Cureus"},{"issue":"3","key":"4656_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgeb.2025.100510","volume":"23","author":"MM Elfadil","year":"2025","unstructured":"Elfadil MM, Samhoon SOA, Saadaldin MM, Ibrahim SAE, Mohamed AAM, Suliman OH, et al. Reverse vaccinology and immunoinformatics approaches for multi-epitope vaccine design against Klebsiella pneumoniae reveal a novel vaccine target protein. J Genetic Eng Biotechnol. 2025;23(3):100510.","journal-title":"J Genetic Eng Biotechnol"},{"issue":"1","key":"4656_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/S1473-3099(15)00416-8","volume":"16","author":"M Osterholm","year":"2016","unstructured":"Osterholm M, Moore K, Ostrowsky J, Kimball-Baker K, Farrar J. The Ebola vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats. Lancet Infect Dis. 2016;16(1):e1\u20139.","journal-title":"Lancet Infect Dis"},{"key":"4656_CR19","doi-asserted-by":"crossref","unstructured":"Sanders B, Koldijk M, Schuitemaker H. Inactivated Viral Vaccines. In: Nunnally BK, Turula VE, Sitrin RD, editors. Vaccine analysis: strategies, principles, and control. Berlin, Heidelberg: Springer Berlin Heidelberg; 2015. p. 45\u201380.","DOI":"10.1007\/978-3-662-45024-6_2"},{"key":"4656_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bpobgyn.2021.02.002","volume":"76","author":"M Arora","year":"2021","unstructured":"Arora M, Lakshmi R. Vaccines - safety in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2021;76:23\u201340.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"4656_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407241","volume":"12","author":"YD Tang","year":"2025","unstructured":"Tang YD, Li Y, Cai XH, Yin X. Viral live-attenuated vaccines (LAVs): past and future directions. Adv Sci (Weinh). 2025;12(3):e2407241.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"4656_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407241","volume":"12","author":"YD Tang","year":"2025","unstructured":"Tang YD, Li Y, Cai XH, Yin X. Viral live\u2010attenuated vaccines (LAVs): past and future directions. Adv Sci (Weinh). 2025;12(3):2407241.","journal-title":"Adv Sci (Weinh)"},{"key":"4656_CR23","doi-asserted-by":"publisher","first-page":"1138016","DOI":"10.3389\/fmicb.2023.1138016","volume":"14","author":"Z Nie","year":"2023","unstructured":"Nie Z, Zhu S, Wu L, Sun R, Shu J, He Y, et al. Progress on innate immune evasion and live attenuated vaccine of pseudorabies virus. Front Microbiol. 2023;14:1138016.","journal-title":"Front Microbiol"},{"issue":"12","key":"4656_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121401","volume":"12","author":"L Kutumbetov","year":"2024","unstructured":"Kutumbetov L, Myrzakhmetova B, Tussipova A, Zhapparova G, Tlenchiyeva T, Bissenbayeva K, et al. Safety and immunogenicity of the live attenuated vaccine QazCOVID-Live against coronavirus infection COVID-19: pre-clinical study results. Vaccines. 2024;12(12):1401.","journal-title":"Vaccines"},{"issue":"10","key":"4656_CR25","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.3390\/v15102089","volume":"15","author":"QL Truong","year":"2023","unstructured":"Truong QL, Wang L, Nguyen TA, Nguyen HT, Tran SD, Vu AT, et al. A cell-adapted live-attenuated vaccine candidate protects pigs against the homologous strain VNUA-ASFV-05L1, a representative strain of the contemporary pandemic African swine fever virus. Viruses. 2023;15(10):2089.","journal-title":"Viruses"},{"key":"4656_CR26","doi-asserted-by":"crossref","unstructured":"Starshinova A, Kudryavtsev I, Rubinstein A, Dovgalyuk I, Kulpina A, Churilov LP, et al. BCG vaccination: historical role, modern applications, and future perspectives in tuberculosis and beyond. Frontiers in Pediatrics. 2025 Volume 13 - 2025.","DOI":"10.3389\/fped.2025.1603732"},{"key":"4656_CR27","doi-asserted-by":"crossref","unstructured":"Lawrence A. Bacillus Calmette-Gu\u00e9rin (BCG) revaccination and protection against tuberculosis: a systematic review. Cureus. 2024 16(3).","DOI":"10.7759\/cureus.56643"},{"issue":"11","key":"4656_CR28","volume":"16","author":"AD Kaye","year":"2024","unstructured":"Kaye AD, Giles TP, O\u2019Brien E, Zajac J, Upshaw WC, Jenks K, et al. Bacillus Calmette-Gu\u00e9rin (BCG) vaccine in America and overseas: a narrative review. Cureus. 2024;16(11):e73602.","journal-title":"Cureus"},{"key":"4656_CR29","doi-asserted-by":"publisher","first-page":"1219006","DOI":"10.3389\/fimmu.2023.1219006","volume":"14","author":"KJ Jensen","year":"2023","unstructured":"Jensen KJ, Hansen MS, Skovgaard K, Svensson E, Larsen LE, Heegaard PM, et al. Immunogenicity of Bacillus Calmette-Gu\u00e9rin in pigs: potential as a translational model of non-specific effects of BCG. Front Immunol. 2023;14:1219006.","journal-title":"Front Immunol"},{"key":"4656_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111946","author":"R Bezbaruah","year":"2022","unstructured":"Bezbaruah R, Chavda VP, Nongrang L, Alom S, Deka K, Kalita T, et al. Nanoparticle-based delivery systems for vaccines. Vaccines. 2022. https:\/\/doi.org\/10.3390\/vaccines10111946.","journal-title":"Vaccines"},{"key":"4656_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/biom14081036","author":"N Parvin","year":"2024","unstructured":"Parvin N, Joo SW, Mandal TK. Enhancing vaccine efficacy and stability: a review of the utilization of nanoparticles in mRNA vaccines. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14081036.","journal-title":"Biomolecules"},{"key":"4656_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13020126","author":"M Saleh","year":"2025","unstructured":"Saleh M, El-Moghazy A, Elgohary AH, Saber WIA, Helmy YA. Revolutionizing nanovaccines: a new era of immunization. Vaccines. 2025. https:\/\/doi.org\/10.3390\/vaccines13020126.","journal-title":"Vaccines"},{"issue":"4","key":"4656_CR33","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11427-022-2230-4","volume":"66","author":"T Li","year":"2023","unstructured":"Li T, Qian C, Gu Y, Zhang J, Li S, Xia N. Current progress in the development of prophylactic and therapeutic vaccines. Sci China Life Sci. 2023;66(4):679\u2013710.","journal-title":"Sci China Life Sci"},{"key":"4656_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071232","author":"KW Kwong","year":"2023","unstructured":"Kwong KW, Xin Y, Lai NC, Sung JC, Wu KC, Hamied YK, et al. Oral vaccines: a better future of immunization. Vaccines. 2023. https:\/\/doi.org\/10.3390\/vaccines11071232.","journal-title":"Vaccines"},{"issue":"3","key":"4656_CR35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1021\/acs.bioconjchem.7b00692","volume":"29","author":"P Angsantikul","year":"2018","unstructured":"Angsantikul P, Fang RH, Zhang L. Toxoid vaccination against bacterial infection using cell membrane-coated nanoparticles. Bioconjug Chem. 2018;29(3):604\u201312.","journal-title":"Bioconjug Chem"},{"issue":"5","key":"4656_CR36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.24171\/j.phrp.2018.9.5.10","volume":"9","author":"CW Choi","year":"2018","unstructured":"Choi CW, Moon JH, Kim JO, Yoo SH, Kim HG, Kim JH, et al. Evaluation of potency on diphtheria and tetanus toxoid for adult vaccines by in vivo toxin neutralization assay using national reference standards. Osong Public Health Res Perspect. 2018;9(5):278\u201382.","journal-title":"Osong Public Health Res Perspect"},{"issue":"1","key":"4656_CR37","volume":"18","author":"B Pawar","year":"2026","unstructured":"Pawar B, Loganathan S, Mukkatira Belliappa K, Ranganathan LB, Thekdi KP, Hiware SD. A comprehensive review of vaccine development: from traditional platforms to messenger RNA (mRNA) technologies. Cureus. 2026;18(1):e100608.","journal-title":"Cureus"},{"key":"4656_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121490","author":"M Ghattas","year":"2021","unstructured":"Ghattas M, Dwivedi G, Lavertu M, Alameh MG. Vaccine technologies and platforms for infectious diseases: current progress, challenges, and opportunities. Vaccines. 2021. https:\/\/doi.org\/10.3390\/vaccines9121490.","journal-title":"Vaccines"},{"issue":"2","key":"4656_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2022.152317","volume":"228","author":"K Pondman","year":"2023","unstructured":"Pondman K, Le Gac S, Kishore U. Nanoparticle-induced immune response: health risk versus treatment opportunity? Immunobiology. 2023;228(2):152317.","journal-title":"Immunobiology"},{"issue":"11","key":"4656_CR40","first-page":"1946","volume":"10","author":"R Bezbaruah","year":"2022","unstructured":"Bezbaruah R, Chavda VP, Nongrang L, Alom S, Deka K, Kalita T, et al. Nanoparticle-based delivery systems for vaccines Vaccines. 2022;10(11):1946.","journal-title":"Nanoparticle-based delivery systems for vaccines Vaccines"},{"issue":"1","key":"4656_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13567-024-01383-x","volume":"55","author":"M Ren","year":"2024","unstructured":"Ren M, Abdullah SW, Pei C, Guo H, Sun S. Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections. Vet Res. 2024;55(1):128.","journal-title":"Vet Res"},{"key":"4656_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218019","author":"P Sabourian","year":"2020","unstructured":"Sabourian P, Yazdani G, Ashraf SS, Frounchi M, Mashayekhan S, Kiani S, et al. Effect of physico-chemical properties of nanoparticles on their intracellular uptake. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21218019.","journal-title":"Int J Mol Sci"},{"key":"4656_CR43","first-page":"477","volume-title":"Nanoparticle-based vaccines and future vaccine technologies","author":"SS Vasudevan","year":"2024","unstructured":"Vasudevan SS, Kandrikar TY, Sayyed AA, Sarker P, Nasir NS, Venugopalan S, et al. Nanoparticle-based vaccines and future vaccine technologies. Advanced Vaccination Technologies for Infectious and Chronic Diseases: Elsevier; 2024. p. 477\u201395."},{"key":"4656_CR44","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/abe5fa","author":"TR Kyriakides","year":"2021","unstructured":"Kyriakides TR, Raj A, Tseng TH, Xiao H, Nguyen R, Mohammed FS, et al. Biocompatibility of nanomaterials and their immunological properties. Biomed Mater. 2021. https:\/\/doi.org\/10.1088\/1748-605X\/abe5fa.","journal-title":"Biomed Mater"},{"issue":"5","key":"4656_CR45","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1166\/jbn.2022.3347","volume":"18","author":"S Song","year":"2022","unstructured":"Song S, Xu H, Yang Y, Wan Q, He B, Cai F, et al. Assessing the efficacy of a tumor nanovaccine and artificial antigen presenting cell-based system as a combination therapy in a mouse model of melanoma. J Biomed Nanotechnol. 2022;18(5):1362\u201375.","journal-title":"J Biomed Nanotechnol"},{"key":"4656_CR46","first-page":"29","volume":"433","author":"EA Grego","year":"2021","unstructured":"Grego EA, Siddoway AC, Uz M, Liu L, Christiansen JC, Ross KA, et al. Polymeric nanoparticle-based vaccine adjuvants and delivery vehicles. Curr Top Microbiol Immunol. 2021;433:29\u201376.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"7","key":"4656_CR47","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/vaccines11071172","volume":"11","author":"B Filipi\u0107","year":"2023","unstructured":"Filipi\u0107 B, Panteli\u0107 I, Nikoli\u0107 I, Majhen D, Stoji\u0107-Vukani\u0107 Z, Savi\u0107 S, et al. Nanoparticle-based adjuvants and delivery systems for modern vaccines. Vaccines. 2023;11(7):1172.","journal-title":"Vaccines"},{"key":"4656_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114294","author":"FA Hamid","year":"2025","unstructured":"Hamid FA, Rostamizadeh K, Skiados N, Le N-MN, Walter DL, Hannon B, et al. Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders. J Control Release. 2025. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114294.","journal-title":"J Control Release"},{"issue":"2","key":"4656_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13020126","volume":"13","author":"M Saleh","year":"2025","unstructured":"Saleh M, El-Moghazy A, Elgohary AH, Saber WIA, Helmy YA. Revolutionizing nanovaccines: a new era of immunization. Vaccines. 2025;13(2):126.","journal-title":"Vaccines"},{"issue":"1","key":"4656_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","volume":"22","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, et al. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023;22(1):169.","journal-title":"Mol Cancer"},{"key":"4656_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101136","volume":"27","author":"C Jin","year":"2024","unstructured":"Jin C, Zhang Y, Li B, Gao T, Wang B, Hua P. Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1\/PD-L1 blockade. Mater Today Bio. 2024;27:101136.","journal-title":"Mater Today Bio"},{"key":"4656_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106960","volume":"108","author":"VV Sugandhi","year":"2025","unstructured":"Sugandhi VV, Gadhave DG, Khot SV, Jadhav K, Patel D, Thapa R, et al. Exploring natural components in vaccine delivery systems: Types, routes of administration, in-vitro and in-vivo quantification techniques. J Drug Delivery Sci Technol. 2025;108:106960.","journal-title":"J Drug Delivery Sci Technol"},{"issue":"1","key":"4656_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12985-025-02645-6","volume":"22","author":"KY Leong","year":"2025","unstructured":"Leong KY, Tham SK, Poh CL. Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications. Virol J. 2025;22(1):71.","journal-title":"Virol J"},{"issue":"5","key":"4656_CR54","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bsheal.2023.05.005","volume":"5","author":"Z Gong","year":"2023","unstructured":"Gong Z, Li H, Qian M, Bai Y, Jin H, Sun J, et al. Incorporation of Escherichia coli heat-labile enterotoxin B subunit into rabies virus particles enhances its immunogenicity in mice and dogs. Biosaf Health. 2023;5(5):308\u201319.","journal-title":"Biosaf Health"},{"key":"4656_CR55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.prevetmed.2018.07.011","volume":"158","author":"F Yahiaoui","year":"2018","unstructured":"Yahiaoui F, Kardjadj M, Laidoudi Y, Medkour H, Ben-Mahdi MH. The epidemiology of dog rabies in Algeria: retrospective national study of dog rabies cases, determination of vaccination coverage and immune response evaluation of three commercial used vaccines. Prev Vet Med. 2018;158:65\u201370.","journal-title":"Prev Vet Med"},{"issue":"9-10","key":"4656_CR56","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.micinf.2018.01.005","volume":"20","author":"PN Frantz","year":"2018","unstructured":"Frantz PN, Teeravechyan S, Tangy F. Measles-derived vaccines to prevent emerging viral diseases. Microbes Infect. 2018;20(9\u201310):493\u2013500.","journal-title":"Microbes Infect"},{"key":"4656_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02180-19","author":"P Wang","year":"2019","unstructured":"Wang P, Zheng M, Lau SY, Chen P, Mok BW, Liu S, et al. Generation of DelNS1 influenza viruses: a strategy for optimizing live attenuated influenza vaccines. MBio. 2019. https:\/\/doi.org\/10.1128\/mBio.02180-19.","journal-title":"MBio"},{"key":"4656_CR58","doi-asserted-by":"publisher","first-page":"1574941","DOI":"10.3389\/fimmu.2025.1574941","volume":"16","author":"S Budroni","year":"2025","unstructured":"Budroni S, Faenzi E, Tavarini S, Sammicheli C, Buricchi F, Volpini G, et al. Distinct effects of adjuvants on B cell responses to protein or polysaccharide antigens contained in glycoconjugate vaccines. Front Immunol. 2025;16:1574941.","journal-title":"Front Immunol"},{"issue":"3","key":"4656_CR59","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1021\/acs.bioconjchem.7b00478","volume":"29","author":"Z Xu","year":"2018","unstructured":"Xu Z, Moyle PM. Bioconjugation approaches to producing subunit vaccines composed of protein or peptide antigens and covalently attached Toll-like receptor ligands. Bioconjug Chem. 2018;29(3):572\u201386.","journal-title":"Bioconjug Chem"},{"issue":"1","key":"4656_CR60","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1021\/acs.molpharmaceut.2c00635","volume":"20","author":"LA Austin","year":"2023","unstructured":"Austin LA, Smith JS, Nahas DD, Danzinger A, Secore S, O\u2019Donnell G, et al. Split-dose administration enhances immune responses elicited by a mRNA\/Lipid nanoparticle vaccine expressing respiratory syncytial virus F protein. Mol Pharm. 2023;20(1):279\u201389.","journal-title":"Mol Pharm"},{"key":"4656_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050530","author":"I Vlatkovic","year":"2021","unstructured":"Vlatkovic I. Non-immunotherapy application of LNP-mRNA: maximizing efficacy and safety. Biomed. 2021. https:\/\/doi.org\/10.3390\/biomedicines9050530.","journal-title":"Biomed"},{"issue":"3","key":"4656_CR62","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.arcmed.2023.02.003","volume":"54","author":"D Tapia","year":"2023","unstructured":"Tapia D, Reyes-Sandoval A, Sanchez-Villamil JI. Protein-based nanoparticle vaccine approaches against infectious diseases. Arch Med Res. 2023;54(3):168\u201375.","journal-title":"Arch Med Res"},{"issue":"1","key":"4656_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","volume":"9","author":"Y Huang","year":"2024","unstructured":"Huang Y, Guo X, Wu Y, Chen X, Feng L, Xie N, et al. Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal Transduct Target Ther. 2024;9(1):34.","journal-title":"Signal Transduct Target Ther"},{"key":"4656_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113827","volume":"383","author":"S Xu","year":"2025","unstructured":"Xu S, Sun C, Qian T, Chen Y, Dong X, Wang A, et al. Animal vaccine revolution: nanoparticle adjuvants open the future of vaccinology. J Control Release. 2025;383:113827.","journal-title":"J Control Release"},{"key":"4656_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2024.1382266","volume":"4","author":"A Peletta","year":"2024","unstructured":"Peletta A, Marmy A, Guzelj S, Ramos Barros A, Jakopin Z, Borchard G. Preliminary results on novel adjuvant combinations suggest enhanced immunogenicity of whole inactivated pandemic influenza vaccines. Front Drug Deliv. 2024;4:1382266.","journal-title":"Front Drug Deliv"},{"key":"4656_CR66","doi-asserted-by":"crossref","unstructured":"Zhou L, Yi W, Zhang Z, Shan X, Zhao Z, Sun X, et al. STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy. Natl Sci Rev. 2023 10(10):nwad214.","DOI":"10.1093\/nsr\/nwad214"},{"key":"4656_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114829","volume":"254","author":"A-G Niculescu","year":"2025","unstructured":"Niculescu A-G, Dumitrascu A-M, Ko\u00e7er AT, Aray\u0131c\u0131 PP, Yuka SA, Ko\u00e7er S, et al. Nanotechnology-driven enhancement and modulation of immune responses in monkeypox and respiratory syncytial virus nanovaccine research. Colloids Surf, B. 2025;254:114829.","journal-title":"Colloids Surf, B"},{"key":"4656_CR68","doi-asserted-by":"crossref","unstructured":"Lopes Chaves L, Dourado D, Prunache IB, Manuelle Marques da Silva P, Tacyana Dos Santos Lucena G, Cardoso de Souza Z, et al. Nanocarriers of antigen proteins for vaccine delivery. Int J Pharm. 2024 659 124162.","DOI":"10.1016\/j.ijpharm.2024.124162"},{"key":"4656_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxnano.2024.100129","volume":"7","author":"F Kurul","year":"2025","unstructured":"Kurul F, Turkmen H, Cetin AE, Topkaya SN. Nanomedicine: how nanomaterials are transforming drug delivery, bio-imaging, and diagnosis. Next Nanotechnol. 2025;7:100129.","journal-title":"Next Nanotechnol"},{"issue":"6","key":"4656_CR70","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","volume":"3","author":"M Mehta","year":"2023","unstructured":"Mehta M, Bui TA, Yang X, Aksoy Y, Goldys EM, Deng W. Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development. ACS Mater Au. 2023;3(6):600\u201319.","journal-title":"ACS Mater Au"},{"key":"4656_CR71","doi-asserted-by":"crossref","unstructured":"Shah S, Madhu H, Soniwala M, Mori D, Vyas A, Chauhan A, et al. Lipid\u2010based nanoparticles. nanocarrier vaccines: biopharmaceutics\u2010based fast track development. 2024:241\u201373.","DOI":"10.1002\/9781394175482.ch7"},{"key":"4656_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126420","volume":"687","author":"R Kumar","year":"2026","unstructured":"Kumar R, Kommineni N, Aadil KR, Desai N, Bunekar N, Salave S, et al. Lipid nanoparticle-based mRNA therapeutics for infectious diseases. Int J Pharm. 2026;687:126420.","journal-title":"Int J Pharm"},{"issue":"7","key":"4656_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12070727","volume":"12","author":"Y Lin","year":"2024","unstructured":"Lin Y, Chen X, Wang K, Liang L, Zhang H. An overview of nanoparticle-based delivery platforms for mRNA vaccines for treating cancer. Vaccines. 2024;12(7):727.","journal-title":"Vaccines"},{"issue":"4","key":"4656_CR74","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines\u2014a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261\u201379.","journal-title":"Nat Rev Drug Discov"},{"key":"4656_CR75","doi-asserted-by":"crossref","unstructured":"Xu X, Cui L, Zhang Y, Gu J. Deciphering the biological fate of mRNA-LNP-based biologics: a perspective from tissue to intracellular distribution. Acta Pharmaceutica Sinica B. 2025.","DOI":"10.1016\/j.apsb.2025.11.023"},{"key":"4656_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.922301","volume":"13","author":"T Huang","year":"2022","unstructured":"Huang T, Peng L, Han Y, Wang D, He X, Wang J, et al. Lipid nanoparticle-based mRNA vaccines in cancers: current advances and future prospects. Front Immunol. 2022;13:922301.","journal-title":"Front Immunol"},{"issue":"1","key":"4656_CR77","first-page":"3","volume":"45","author":"I Luki\u0107","year":"2024","unstructured":"Luki\u0107 I, Draga\u010devi\u0107 L, Pani\u0107 M, Stamenkovi\u0107 M, Koji\u0107 M. mRNA vaccine manufacturing\u2013challenges in plasmid DNA cloning vector design. Microbiol\/Mikrobiol. 2024;45(1):3\u20139.","journal-title":"Microbiol\/Mikrobiol"},{"key":"4656_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115764","author":"R Ashfaq","year":"2023","unstructured":"Ashfaq R, Rasul A, Asghar S, Kov\u00e1cs A, Berk\u00f3 S, Budai-Sz\u0171cs M. Lipid nanoparticles: an effective tool to improve the bioavailability of nutraceuticals. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242115764.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4656_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70414","volume":"6","author":"X Li","year":"2025","unstructured":"Li X, Li J, Wei J, Du W, Su C, Shen X, et al. Design strategies for novel lipid nanoparticle for mRNA vaccine and therapeutics: current understandings and future perspectives. MedComm. 2025;6(10):e70414.","journal-title":"MedComm"},{"issue":"11","key":"4656_CR80","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","volume":"55","author":"R Verbeke","year":"2022","unstructured":"Verbeke R, Hogan MJ, Lor\u00e9 K, Pardi N. Innate immune mechanisms of mRNA vaccines. Immunity. 2022;55(11):1993\u20132005.","journal-title":"Immunity"},{"issue":"4","key":"4656_CR81","doi-asserted-by":"publisher","DOI":"10.53388\/IDR20221125022","volume":"3","author":"H Banoun","year":"2022","unstructured":"Banoun H. Current state of knowledge on the excretion of mRNA and spike produced by anti-COVID-19 mRNA vaccines; possibility of contamination of the entourage of those vaccinated by these products. Infectious Diseases Res. 2022;3(4):22.","journal-title":"Infectious Diseases Res"},{"issue":"12","key":"4656_CR82","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078\u201394.","journal-title":"Nat Rev Mater"},{"issue":"11","key":"4656_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70434","volume":"6","author":"J Li","year":"2025","unstructured":"Li J, Liu Y, Dai J, Yang L, Xiong F, Xia J, et al. mRNA vaccines: current applications and future directions. MedComm. 2025;6(11):e70434.","journal-title":"MedComm"},{"key":"4656_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1709794","volume":"16","author":"H Chen","year":"2025","unstructured":"Chen H, Gu Y, Song L, Si L. Next-generation vaccines against bacterial pathogens: mRNA and beyond. Front Immunol. 2025;16:1709794.","journal-title":"Front Immunol"},{"key":"4656_CR85","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.nano.2018.11.005","volume":"18","author":"JD Bazzill","year":"2019","unstructured":"Bazzill JD, Stronsky SM, Kalinyak LC, Ochyl LJ, Steffens JT, van Tongeren SA, et al. Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses. Nanomed. 2019;18:414\u201325.","journal-title":"Nanomed"},{"issue":"26","key":"4656_CR86","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1039\/D0TB00892C","volume":"8","author":"JW Lim","year":"2020","unstructured":"Lim JW, Na W, Kim HO, Yeom M, Kang A, Park G, et al. Co-delivery of antigens and immunostimulants via a polymersome for improvement of antigen-specific immune response. J Mater Chem B. 2020;8(26):5620\u20136.","journal-title":"J Mater Chem B"},{"key":"4656_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/nano10050906","author":"ST Chuang","year":"2020","unstructured":"Chuang ST, Cruz S, Narayanaswami V. Reconfiguring Nature\u2019s cholesterol accepting lipoproteins as nanoparticle platforms for transport and delivery of therapeutic and imaging agents. Nanomaterials. 2020. https:\/\/doi.org\/10.3390\/nano10050906.","journal-title":"Nanomaterials"},{"issue":"12","key":"4656_CR88","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1586\/14760584.2015.1091732","volume":"14","author":"CH Leng","year":"2015","unstructured":"Leng CH, Liu SJ, Chen HW, Chong P. Recombinant bacterial lipoproteins as vaccine candidates. Expert Rev Vaccines. 2015;14(12):1623\u201332.","journal-title":"Expert Rev Vaccines"},{"key":"4656_CR89","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-1-4939-3387-7_20","volume":"1403","author":"J Karczewski","year":"2016","unstructured":"Karczewski J, Bodmer JL, Cook JC, Xoconostle RF, Nahas DD, Joyce JG, et al. Design and purification of subunit vaccines for prevention of clostridium difficile infection. Methods Mol Biol. 2016;1403:385\u201396.","journal-title":"Methods Mol Biol"},{"key":"4656_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxnano.2025.100209","volume":"8","author":"R Chelliah","year":"2025","unstructured":"Chelliah R, Rubab M, Vijayalakshmi S, Karuvelan M, Barathikannan K, Oh D-H. Liposomes for drug delivery: classification, therapeutic applications, and limitations. Next Nanotechnol. 2025;8:100209.","journal-title":"Next Nanotechnol"},{"key":"4656_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8030081","author":"JJ Janicki","year":"2016","unstructured":"Janicki JJ, Chancellor MB, Kaufman J, Gruber MA, Chancellor DD. Potential effect of liposomes and liposome-encapsulated Botulinum Toxin and Tacrolimus in the treatment of bladder dysfunction. Toxins (Basel). 2016. https:\/\/doi.org\/10.3390\/toxins8030081.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"4656_CR92","first-page":"1","volume":"16","author":"DS Tretiakova","year":"2022","unstructured":"Tretiakova DS, Vodovozova EL. Liposomes as adjuvants and vaccine delivery systems. Biochem (Mosc) Suppl Ser A Membr Cell Biol. 2022;16(1):1\u201320.","journal-title":"Biochem (Mosc) Suppl Ser A Membr Cell Biol"},{"issue":"1","key":"4656_CR93","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1080\/14760584.2023.2274479","volume":"22","author":"S Zhou","year":"2023","unstructured":"Zhou S, Luo Y, Lovell JF. Vaccine approaches for antigen capture by liposomes. Expert Rev Vaccines. 2023;22(1):1022\u201340.","journal-title":"Expert Rev Vaccines"},{"key":"4656_CR94","volume":"10","author":"MJ Javid-Naderi","year":"2025","unstructured":"Javid-Naderi MJ, Mousavi Shaegh SA. Advanced microfluidic techniques for the preparation of solid lipid nanoparticles: innovations and biomedical applications. Int J Pharm X. 2025;10:100399.","journal-title":"Int J Pharm X"},{"issue":"4","key":"4656_CR95","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12551-023-01089-y","volume":"15","author":"AS Palma","year":"2023","unstructured":"Palma AS, Casadei BR, Lotierzo MC, de Castro RD, Barbosa LRS. A short review on the applicability and use of cubosomes as nanocarriers. Biophys Rev. 2023;15(4):553\u201367.","journal-title":"Biophys Rev"},{"key":"4656_CR96","doi-asserted-by":"crossref","unstructured":"McClements DJ, Ozturk B. Utilization of nanotechnology to improve the handling, storage and biocompatibility of bioactive lipids in food applications. Foods. 2021 10(2).","DOI":"10.3390\/foods10020365"},{"key":"4656_CR97","doi-asserted-by":"crossref","unstructured":"Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019 8(7).","DOI":"10.3390\/cells8070727"},{"issue":"3","key":"4656_CR98","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13205-023-03521-2","volume":"13","author":"S Sen","year":"2023","unstructured":"Sen S, Xavier J, Kumar N, Ahmad MZ, Ranjan OP. Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives. 3 Biotech. 2023;13(3):101.","journal-title":"3 Biotech"},{"key":"4656_CR99","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.canlet.2020.05.036","volume":"489","author":"YK Kim","year":"2020","unstructured":"Kim YK, Choi Y, Nam GH, Kim IS. Functionalized exosome harboring bioactive molecules for cancer therapy. Cancer Lett. 2020;489:155\u201362.","journal-title":"Cancer Lett"},{"key":"4656_CR100","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ijbiomac.2021.04.005","volume":"182","author":"K Asadi","year":"2021","unstructured":"Asadi K, Gholami A. Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: a review. Int J Biol Macromol. 2021;182:648\u201358.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"4656_CR101","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1134\/S0026893321030158","volume":"55","author":"AN Vzorov","year":"2021","unstructured":"Vzorov AN, Samokhvalov EI, Chebanenko VV, Scheblyakov DV, Gintsburg AL. Modification of the spike protein for vaccines against enveloped RNA viruses. Mol Biol. 2021;55(4):538\u201347.","journal-title":"Mol Biol"},{"issue":"2","key":"4656_CR102","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1021\/mp4005029","volume":"11","author":"PT Wong","year":"2014","unstructured":"Wong PT, Wang SH, Ciotti S, Makidon PE, Smith DM, Fan Y, et al. Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity. Mol Pharm. 2014;11(2):531\u201344.","journal-title":"Mol Pharm"},{"key":"4656_CR103","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.2147\/IJN.S379950","volume":"17","author":"GE Chae","year":"2022","unstructured":"Chae GE, Kim DW, Jin HE. Development of Squalene-based oil-in-water emulsion adjuvants using a self-emulsifying drug delivery system for enhanced antigen-specific antibody titers. Int J Nanomedicine. 2022;17:6221\u201331.","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"4656_CR104","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1021\/acsnano.8b07961","volume":"13","author":"J Zhai","year":"2019","unstructured":"Zhai J, Fong C, Tran N, Drummond CJ. Non-lamellar lyotropic liquid crystalline lipid nanoparticles for the next generation of nanomedicine. ACS Nano. 2019;13(6):6178\u2013206.","journal-title":"ACS Nano"},{"issue":"10","key":"4656_CR105","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1002\/anie.201804067","volume":"58","author":"HMG Barriga","year":"2019","unstructured":"Barriga HMG, Holme MN, Stevens MM. Cubosomes: The next generation of smart lipid nanoparticles? Angew Chem Int Ed Engl. 2019;58(10):2958\u201378.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"45","key":"4656_CR106","first-page":"24765","volume":"145","author":"H Yu","year":"2023","unstructured":"Yu H, Iscaro J, Dyett B, Zhang Y, Seibt S, Martinez N, et al. Inverse cubic and hexagonal mesophase evolution within ionizable lipid nanoparticles correlates with mRNA transfection in macrophages. J Am Chem Soc. 2023;145(45):24765\u201374.","journal-title":"J Am Chem Soc"},{"issue":"8","key":"4656_CR107","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.apsb.2021.01.020","volume":"11","author":"QV Le","year":"2021","unstructured":"Le QV, Lee J, Lee H, Shim G, Oh YK. Cell membrane-derived vesicles for delivery of therapeutic agents. Acta Pharm Sin B. 2021;11(8):2096\u2013113.","journal-title":"Acta Pharm Sin B"},{"key":"4656_CR108","doi-asserted-by":"crossref","unstructured":"Elmowafy M, Shalaby K, Elkomy MH, Alsaidan OA, Gomaa HAM, Abdelgawad MA, et al. Polymeric nanoparticles for delivery of natural bioactive agents: recent advances and challenges. Polymers (Basel). 2023;15(5).","DOI":"10.3390\/polym15051123"},{"issue":"Pt 1","key":"4656_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129350","volume":"262","author":"M Zeshan","year":"2024","unstructured":"Zeshan M, Amjed N, Ashraf H, Farooq A, Akram N, Zia KM. A review on the application of chitosan-based polymers in liver tissue engineering. Int J Biol Macromol. 2024;262(Pt 1):129350.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"4656_CR110","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1248\/cpb.c24-00334","volume":"72","author":"P Raghuveer","year":"2024","unstructured":"Raghuveer P, Shanthi D, Kumar TU, Rao PL, Sriharsha K, Madhuri D, et al. Aqueous dispersion polymerization for the development of lamivudine-Polyacrylonitrile nanoparticles through quality by design approach. Chem Pharm Bull (Tokyo). 2024;72(11):950\u201360.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"4656_CR111","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez A, Mej\u00eda SP, Orozco J. Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections. Molecules. 2020 25(16).","DOI":"10.3390\/molecules25163760"},{"key":"4656_CR112","doi-asserted-by":"crossref","unstructured":"Pippa N, Gazouli M, Pispas S. Recent Advances and Future Perspectives in Polymer-Based Nanovaccines. Vaccines (Basel). 2021 9(6).","DOI":"10.3390\/vaccines9060558"},{"issue":"2","key":"4656_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1853","volume":"15","author":"J Yang","year":"2023","unstructured":"Yang J, Luly KM, Green JJ. Nonviral nanoparticle gene delivery into the CNS for neurological disorders and brain cancer applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15(2):e1853.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"4656_CR114","volume":"10","author":"Y Shi","year":"2025","unstructured":"Shi Y, Zhu L, Qiao Z, Zhai Y, Di J, Wang S, et al. Polymeric particle-based antigen delivery system: From immunological engineering to clinical translation. Int J Pharm X. 2025;10:100466.","journal-title":"Int J Pharm X"},{"key":"4656_CR115","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","volume":"332","author":"M Ghezzi","year":"2021","unstructured":"Ghezzi M, Pescina S, Padula C, Santi P, Del Favero E, Cant\u00f9 L, et al. Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release. 2021;332:312\u201336.","journal-title":"J Control Release"},{"issue":"2","key":"4656_CR116","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s13205-021-03105-y","volume":"12","author":"R Mundel","year":"2022","unstructured":"Mundel R, Thakur T, Chatterjee M. Emerging uses of PLA-PEG copolymer in cancer drug delivery. 3 Biotech. 2022;12(2):41.","journal-title":"3 Biotech"},{"issue":"9","key":"4656_CR117","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, et al. Polymeric nanoparticles for drug delivery. Chem Rev. 2024;124(9):5505\u2013616.","journal-title":"Chem Rev"},{"key":"4656_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125673","volume":"246","author":"S Yadav","year":"2023","unstructured":"Yadav S, Chamoli S, Kumar P, Maurya PK. Structural and functional insights in polysaccharides coated cerium oxide nanoparticles and their potential biomedical applications: a review. Int J Biol Macromol. 2023;246:125673.","journal-title":"Int J Biol Macromol"},{"issue":"40","key":"4656_CR119","doi-asserted-by":"publisher","first-page":"2204462","DOI":"10.1002\/adfm.202204462","volume":"32","author":"Z Li","year":"2022","unstructured":"Li Z, Zhang XQ, Ho W, Bai X, Jaijyan DK, Li F, et al. Lipid-polymer hybrid \u201cParticle-in-Particle\u201d nanostructure gene delivery platform explored for lyophilizable DNA and mRNA COVID-19 vaccines. Adv Func Mater. 2022;32(40):2204462.","journal-title":"Adv Func Mater"},{"issue":"1","key":"4656_CR120","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/14760584.2023.2218913","volume":"22","author":"E Underwood","year":"2023","unstructured":"Underwood E, Dunkle LM, Madhi SA, Gay CL, Heath PT, Kotloff KL, et al. Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine. Expert Rev Vaccines. 2023;22(1):501\u201317.","journal-title":"Expert Rev Vaccines"},{"key":"4656_CR121","doi-asserted-by":"crossref","unstructured":"Song JY, Choi WS, Heo JY, Kim EJ, Lee JS, Jung DS, et al. Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: randomised, active-controlled, observer-blinded, phase 3 trial. medRxiv. 2023:2023.01. 31.23284895.","DOI":"10.1101\/2023.01.31.23284895"},{"key":"4656_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1542380","volume":"16","author":"S-H Wang","year":"2025","unstructured":"Wang S-H, Serr I, Digigow R, Metzler B, Surnov A, Gottwick C, et al. Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models. Front Immunol. 2025;16:1542380.","journal-title":"Front Immunol"},{"issue":"1","key":"4656_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/nano14010067","volume":"14","author":"S Kusumoputro","year":"2023","unstructured":"Kusumoputro S, Au C, Lam KH, Park N, Hyun A, Kusumoputro E, et al. Liver-targeting nanoplatforms for the induction of immune tolerance. Nanomaterials. 2023;14(1):67.","journal-title":"Nanomaterials"},{"key":"4656_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntm.2025.100083","volume":"4","author":"UE Ewii","year":"2025","unstructured":"Ewii UE, Attama AA, Olorunsola EO, Onugwu AL, Nwakpa FU, Anyiam C, et al. Nanoparticles for drug delivery: Insight into in vitro and in vivo drug release from nanomedicines. Nano TransMed. 2025;4:100083.","journal-title":"Nano TransMed"},{"issue":"8","key":"4656_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/biom14081036","volume":"14","author":"N Parvin","year":"2024","unstructured":"Parvin N, Joo SW, Mandal TK. Enhancing vaccine efficacy and stability: a review of the utilization of nanoparticles in mRNA vaccines. Biomolecules. 2024;14(8):1036.","journal-title":"Biomolecules"},{"issue":"39","key":"4656_CR126","doi-asserted-by":"publisher","first-page":"e12239","DOI":"10.1097\/md.0000000000012239","volume":"97","author":"M Mohseni","year":"2018","unstructured":"Mohseni M, Faghihi R, Haghighatafshar M, Entezarmahdi SM. Effects of the attenuation correction and reconstruction method parameters on conventional cardiac dynamic SPECT. Medicine. 2018;97(39):e12239.  https:\/\/doi.org\/10.1097\/md.0000000000012239.","journal-title":"Medicine"},{"issue":"14","key":"4656_CR127","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1039\/C8AN00731D","volume":"143","author":"A Ghasemi","year":"2018","unstructured":"Ghasemi A, Rabiee N, Ahmadi S, Hashemzadeh S, Lolasi F, Bozorgomid M, et al. Optical assays based on colloidal inorganic nanoparticles. Analyst. 2018;143(14):3249\u201383.","journal-title":"Analyst"},{"key":"4656_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.rsurfi.2025.100635","volume":"21","author":"M Abdullah","year":"2025","unstructured":"Abdullah M, Obayedullah M, Shariful Islam Shuvo M, Abul Khair M, Hossain D, Nahidul Islam M. A review on multifunctional applications of nanoparticles: analyzing their multi-physical properties. Results Surf Interfaces. 2025;21:100635.","journal-title":"Results Surf Interfaces"},{"key":"4656_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118399","volume":"190","author":"MN Amaral","year":"2025","unstructured":"Amaral MN, Kumar P, Fa\u00edsca P, Ferreira HA, Coelho JMP, Gaspar MM, et al. Gold nanoparticle-mediated photothermal therapy: Expanding the frontiers of cancer treatment and theragnostics. Biomed Pharmacother. 2025;190:118399.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4656_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01625-0","volume":"20","author":"S Yasamineh","year":"2022","unstructured":"Yasamineh S, Kalajahi HG, Yasamineh P, Yazdani Y, Gholizadeh O, Tabatabaie R, et al. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. J Nanobiotechnol. 2022;20(1):440.","journal-title":"J Nanobiotechnol"},{"key":"4656_CR131","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJN.S121956","volume":"12","author":"L Wang","year":"2017","unstructured":"Wang L, Hu C, Shao L. The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomedicine. 2017;12:1227\u201349.","journal-title":"Int J Nanomedicine"},{"key":"4656_CR132","doi-asserted-by":"crossref","unstructured":"Wahab S, Salman A, Khan Z, Khan S, Krishnaraj C, Yun SI. Metallic nanoparticles: a promising arsenal against antimicrobial resistance-unraveling mechanisms and enhancing medication efficacy. Int J Mol Sci. 2023;24(19).","DOI":"10.3390\/ijms241914897"},{"key":"4656_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.indcrop.2025.121850","volume":"236","author":"E Amirinezhadfard","year":"2025","unstructured":"Amirinezhadfard E, Tabar AN, Xia L-J, Yang W-C. Plant-derived nanomaterials in cancer therapy: advances from green synthesis to application of PANoptosis-mediated tumor suppression. Ind Crops Prod. 2025;236:121850.","journal-title":"Ind Crops Prod"},{"issue":"1","key":"4656_CR134","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1039\/D5SU00741K","volume":"4","author":"M Rajotia","year":"2025","unstructured":"Rajotia M, Yadav A, Saroj VK, Panda S. Engineering silica nanoparticles for precision nanomedicine: synthesis & functionalization\u2014a review. RSC Sustain. 2025;4(1):142\u201356.","journal-title":"RSC Sustain"},{"issue":"1","key":"4656_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01654-7","volume":"8","author":"B Xu","year":"2023","unstructured":"Xu B, Li S, Shi R, Liu H. Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduct Target Ther. 2023;8(1):435.","journal-title":"Signal Transduct Target Ther"},{"key":"4656_CR136","doi-asserted-by":"crossref","unstructured":"Almatroudi A. Advances in mesoporous silica and hybrid nanoparticles for drug delivery: synthesis, functionalization, and biomedical applications. Pharmaceutics. 2025 17(12).","DOI":"10.3390\/pharmaceutics17121602"},{"issue":"11","key":"4656_CR137","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1080\/14760584.2016.1188009","volume":"15","author":"G Navarro-Tovar","year":"2016","unstructured":"Navarro-Tovar G, Palestino G, Rosales-Mendoza S. An overview on the role of silica-based materials in vaccine development. Expert Rev Vaccines. 2016;15(11):1449\u201362.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"4656_CR138","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02198-8","volume":"16","author":"A Zafar","year":"2025","unstructured":"Zafar A, Khatoon S, Khan MJ, Abu J, Naeem A. Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discov Oncol. 2025;16(1):607.","journal-title":"Discov Oncol"},{"key":"4656_CR139","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.2147\/IJN.S76114","volume":"10","author":"C Guo","year":"2015","unstructured":"Guo C, Xia Y, Niu P, Jiang L, Duan J, Yu Y, et al. Silica nanoparticles induce oxidative stress, inflammation, and endothelial dysfunction in vitro via activation of the MAPK\/Nrf2 pathway and nuclear factor-\u03baB signaling. Int J Nanomed. 2015;10:1463\u201377.","journal-title":"Int J Nanomed"},{"key":"4656_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxnano.2025.100298","volume":"8","author":"N Thirumalaivasan","year":"2025","unstructured":"Thirumalaivasan N, Nangan S, MariaJoseph A, Kanagaraj K. Advancements in hybrid silica nanoparticles for pioneering precision in targeted drug delivery and diagnostic applications. Next Nanotechnol. 2025;8:100298.","journal-title":"Next Nanotechnol"},{"key":"4656_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.cartre.2024.100407","volume":"17","author":"A Salvi","year":"2024","unstructured":"Salvi A, Kharbanda S, Thakur P, Shandilya M, Thakur A. Biomedical application of carbon quantum dots: a review. Carbon Trends. 2024;17:100407.","journal-title":"Carbon Trends"},{"issue":"2","key":"4656_CR142","doi-asserted-by":"publisher","DOI":"10.1088\/1674-4926\/44\/2\/023101","volume":"44","author":"Y Liang","year":"2023","unstructured":"Liang Y, Mao G, Dai J, Ma Y. Biofunctionalized semiconductor quantum dots for virus detection. J Semicond. 2023;44(2):023101.","journal-title":"J Semicond"},{"key":"4656_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126192","volume":"684","author":"RM Percoco","year":"2025","unstructured":"Percoco RM, Schirinzi S, Mandriota G, Cortese B, Gigli G, Palam\u00e0 IE, et al. Smart inorganic nanoparticles in nanomedicine: Strategies for synthesis and functionalization. Int J Pharm. 2025;684:126192.","journal-title":"Int J Pharm"},{"key":"4656_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123604","volume":"371","author":"AB Diaz-Ruano","year":"2025","unstructured":"Diaz-Ruano AB, Gomez-Jimenez E, Llamas-Jimenez G, Ramirez-Mu\u00f1oz A, Espejo-Hijano P, Rubio-Navarro A, et al. Advances in the use of nanoparticles for specific cell-target delivery of anti-cancer agents. Life Sci. 2025;371:123604.","journal-title":"Life Sci"},{"issue":"2","key":"4656_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbe.2025.100038","volume":"18","author":"W Su","year":"2026","unstructured":"Su W, Yang M, Huang S, Huang C, Li Y, Wang A, et al. The application of nanomaterials in vaccine adjuvants. Nano Biomedicine Eng. 2026;18(2):100038.","journal-title":"Nano Biomedicine Eng"},{"key":"4656_CR146","doi-asserted-by":"crossref","unstructured":"Joseph TM, Kar Mahapatra D, Esmaeili A, Piszczyk \u0141, Hasanin MS, Kattali M, et al. Nanoparticles: Taking a Unique Position in Medicine. Nanomaterials (Basel). 2023;13(3).","DOI":"10.3390\/nano13030574"},{"key":"4656_CR147","doi-asserted-by":"crossref","unstructured":"Rold\u00e3o A, Silva AC, Mellado MCM, Alves PM, Carrondo MJT. 1.47 - Viruses and Virus-Like Particles in Biotechnology: Fundamentals and Applications\u2606. In: Moo-Young M, editor. Comprehensive Biotechnology (Third Edition). Oxford: Pergamon; 2017. p. 633\u201356.","DOI":"10.1016\/B978-0-12-809633-8.09046-4"},{"issue":"3","key":"4656_CR148","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.inmuno.2012.08.002","volume":"32","author":"E Crisci","year":"2013","unstructured":"Crisci E, B\u00e1rcena J, Montoya M. Virus-like particle-based vaccines for animal viral infections. Inmunologia. 2013;32(3):102\u201316.","journal-title":"Inmunologia"},{"key":"4656_CR149","doi-asserted-by":"crossref","unstructured":"Barbinta-Patrascu M-E, Negut I, Bita B. Virus biomimetic-delivery systems for the production of vaccines. Biomimetics [Internet]. 2026; 11(2):[150 p.].","DOI":"10.3390\/biomimetics11020150"},{"issue":"1","key":"4656_CR150","volume":"21","author":"VS Egorova","year":"2026","unstructured":"Egorova VS, Kolesova EP, Voronina MV, Denisova ER, Syrocheva AO, Pallaeva T, et al. From bench to bedside: Unveiling the background and benefits of nanovaccines tested in clinics. Asian J Pharm Sci. 2026;21(1):101116.","journal-title":"Asian J Pharm Sci"},{"key":"4656_CR151","doi-asserted-by":"crossref","unstructured":"Facciol\u00e0 A, Visalli G, Lagan\u00e0 A, Di Pietro A. An overview of vaccine adjuvants: current evidence and future perspectives. Vaccines (Basel). 2022;10(5).","DOI":"10.3390\/vaccines10050819"},{"key":"4656_CR152","doi-asserted-by":"publisher","first-page":"1123805","DOI":"10.3389\/fimmu.2023.1123805","volume":"14","author":"R Gupta","year":"2023","unstructured":"Gupta R, Arora K, Roy SS, Joseph A, Rastogi R, Arora NM, et al. Platforms, advances, and technical challenges in virus-like particles-based vaccines. Front Immunol. 2023;14:1123805.","journal-title":"Front Immunol"},{"issue":"5","key":"4656_CR153","doi-asserted-by":"publisher","first-page":"480","DOI":"10.4161\/mabs.2.5.12645","volume":"2","author":"HF Liu","year":"2010","unstructured":"Liu HF, Ma J, Winter C, Bayer R. Recovery and purification process development for monoclonal antibody production. MAbs. 2010;2(5):480\u201399.","journal-title":"MAbs"},{"issue":"4","key":"4656_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101613","volume":"33","author":"J Gostage","year":"2025","unstructured":"Gostage J, Domingo-Lopez DA, Tarpey R, Duffy GP, Levey RE. From cold chain to ambient: benefits, risks, and evidence across cell therapy logistics. Mol Ther Methods Clin Dev. 2025;33(4):101613.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"5","key":"4656_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/v15051109","volume":"15","author":"M Kheirvari","year":"2023","unstructured":"Kheirvari M, Liu H, Tumban E. Virus-like particle vaccines and platforms for vaccine development. Viruses. 2023;15(5):1109.","journal-title":"Viruses"},{"key":"4656_CR156","doi-asserted-by":"crossref","unstructured":"Qian C, Liu X, Xu Q, Wang Z, Chen J, Li T, et al. Recent progress on the versatility of virus-like particles. Vaccines (Basel). 2020;8(1).","DOI":"10.3390\/vaccines8010139"},{"key":"4656_CR157","doi-asserted-by":"crossref","unstructured":"Kheirvari M, Liu H, Tumban E. Virus-like particle vaccines and platforms for vaccine development. Viruses. 2023 15(5).","DOI":"10.3390\/v15051109"},{"issue":"9","key":"4656_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29909","volume":"10","author":"N Almulla","year":"2024","unstructured":"Almulla N, Soltane R, Alasiri A, Kamal Allayeh A, Alqadi T, Alshehri F, et al. Advancements in SARS-CoV-2 detection: Navigating the molecular landscape and diagnostic technologies. Heliyon. 2024;10(9):e29909.","journal-title":"Heliyon"},{"key":"4656_CR159","doi-asserted-by":"crossref","unstructured":"Tang J, Amin MA, Campian JL. Past, present, and future of viral vector vaccine platforms: a comprehensive review. Vaccines (Basel). 2025;13(5).","DOI":"10.3390\/vaccines13050524"},{"key":"4656_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.790121","volume":"12","author":"H Tariq","year":"2022","unstructured":"Tariq H, Batool S, Asif S, Ali M, Abbasi BH. Virus-like particles: revolutionary platforms for developing vaccines against emerging infectious diseases. Front Microbiol. 2022;12:790121.","journal-title":"Front Microbiol"},{"key":"4656_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2025.100351","volume":"7","author":"B Laxmi","year":"2025","unstructured":"Laxmi B, Devi PUM, Naveen T, Buddolla V. Virus-like particles: innovative strategies for combatting emerging and re-emerging viral threats. Microbe. 2025;7:100351.","journal-title":"Microbe"},{"key":"4656_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2025.199601","volume":"358","author":"K Yang","year":"2025","unstructured":"Yang K. Accelerating vaccine development: plug-and-play platforms for emerging infectious diseases. Virus Res. 2025;358:199601.","journal-title":"Virus Res"},{"issue":"11","key":"4656_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111920","volume":"10","author":"F Lamontagne","year":"2022","unstructured":"Lamontagne F, Khatri V, St-Louis P, Bourgault S, Archambault D. Vaccination strategies based on bacterial self-assembling proteins as antigen delivery nanoscaffolds. Vaccines. 2022;10(11):1920.","journal-title":"Vaccines"},{"key":"4656_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122666","volume":"311","author":"Y Li","year":"2024","unstructured":"Li Y, Rodriguez-Otero MR, Champion JA. Self-assembled protein vesicles as vaccine delivery platform to enhance antigen-specific immune responses. Biomaterials. 2024;311:122666.","journal-title":"Biomaterials"},{"key":"4656_CR165","doi-asserted-by":"crossref","unstructured":"Cao S, Ma D, Ji S, Zhou M, Zhu S. Self-assembled ferritin nanoparticles for delivery of antigens and development of vaccines: from structure and property to applications. Molecules. 2024 29(17).","DOI":"10.3390\/molecules29174221"},{"issue":"10","key":"4656_CR166","doi-asserted-by":"publisher","first-page":"2303531","DOI":"10.1002\/adhm.202303531","volume":"13","author":"J Nie","year":"2024","unstructured":"Nie J, Wang Q, Li C, Zhou Y, Yao X, Xu L, et al. Self-Assembled multiepitope nanovaccine provides long-lasting cross-protection against influenza virus. Adv Healthcare Mater. 2024;13(10):2303531.","journal-title":"Adv Healthcare Mater"},{"key":"4656_CR167","first-page":"539","volume":"60","author":"H Fu","year":"2026","unstructured":"Fu H, Gao W, Tang Y, Liu X, Wang M, Zhang J, et al. Programmable next-generation supramolecular self-assembled materials as drug delivery systems. Bioact Mater. 2026;60:539\u201373.","journal-title":"Bioact Mater"},{"issue":"1","key":"4656_CR168","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02411-9","volume":"23","author":"F-F Xu","year":"2025","unstructured":"Xu F-F, Zhao Z, Deng Z-Y, Tang J-L, Zhu B. Self-assembled nanoparticle vaccine comprised of multiple epitopes provides robust protective immunity against reoviruses in fish model. Cell Commun Signal. 2025;23(1):389.","journal-title":"Cell Commun Signal"},{"issue":"51","key":"4656_CR169","doi-asserted-by":"publisher","first-page":"35947","DOI":"10.1039\/D3RA06476J","volume":"13","author":"M Rahban","year":"2023","unstructured":"Rahban M, Ahmad F, Piatyszek MA, Haertl\u00e9 T, Saso L, Saboury AA. Stabilization challenges and aggregation in protein-based therapeutics in the pharmaceutical industry. RSC Adv. 2023;13(51):35947\u201363.","journal-title":"RSC Adv"},{"issue":"1","key":"4656_CR170","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12951-025-03800-5","volume":"24","author":"Y Quan","year":"2025","unstructured":"Quan Y, Yang H, Li W, Li L. mRNA vaccines: immunogenicity and quality characteristics. J Nanobiotechnol. 2025;24(1):6.","journal-title":"J Nanobiotechnol"},{"key":"4656_CR171","doi-asserted-by":"crossref","unstructured":"Zhang MM, Zhu J, Wang ZY, Bai YL, Li HB, Nashun B, et al. Self-Assembled Peptides: A New Generation of Vaccine Adjuvant Platform. Vaccines (Basel). 2025;13(12).","DOI":"10.3390\/vaccines13121183"},{"issue":"1","key":"4656_CR172","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/17425247.2023.2153832","volume":"20","author":"A De","year":"2023","unstructured":"De A, Ko YT. A tale of nucleic acid-ionizable lipid nanoparticles: design and manufacturing technology and advancement. Expert Opin Drug Deliv. 2023;20(1):75\u201391.","journal-title":"Expert Opin Drug Deliv"},{"issue":"26","key":"4656_CR173","doi-asserted-by":"publisher","first-page":"37763","DOI":"10.1021\/acsami.5c08444","volume":"17","author":"C Wang","year":"2025","unstructured":"Wang C, Zhou Y, Gao Y, Pan X, Jia W, Wu T, et al. Lipid nanoparticles consisting of sterol-conjugated ionizable lipids enable prolonged and safe mRNA delivery. ACS Appl Mater Interfaces. 2025;17(26):37763\u201373.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"4656_CR174","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/mabi.201600189","volume":"16","author":"CC Cheng","year":"2016","unstructured":"Cheng CC, Lin IH, Chen JK, Liao ZS, Huang JJ, Lee DJ, et al. Nucleobase-functionalized supramolecular micelles with tunable physical properties for efficient controlled drug release. Macromol Biosci. 2016;16(10):1415\u201321.","journal-title":"Macromol Biosci"},{"issue":"3","key":"4656_CR175","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2174\/1381612822666161027104304","volume":"23","author":"E Elmowafy","year":"2017","unstructured":"Elmowafy E, Osman R, Ishak RA. Polymer-based novel lung targeted delivery systems. Curr Pharm Des. 2017;23(3):373\u201392.","journal-title":"Curr Pharm Des"},{"key":"4656_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118645","volume":"570","author":"M Akbarzadeh","year":"2019","unstructured":"Akbarzadeh M, Babaei M, Abnous K, Taghdisi SM, Peivandi MT, Ramezani M, et al. Hybrid silica-coated Gd-Zn-Cu-In-S\/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Int J Pharm. 2019;570:118645.","journal-title":"Int J Pharm"},{"issue":"25","key":"4656_CR177","doi-asserted-by":"publisher","first-page":"15857","DOI":"10.1021\/acsami.6b02562","volume":"8","author":"X Chen","year":"2016","unstructured":"Chen X, Liu Z, Parker SG, Zhang X, Gooding JJ, Ru Y, et al. Light-induced hydrogel based on tumor-targeting mesoporous silica nanoparticles as a theranostic platform for sustained cancer treatment. ACS Appl Mater Interfaces. 2016;8(25):15857\u201363.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4656_CR178","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1088852","volume":"14","author":"J Armero-Gimenez","year":"2023","unstructured":"Armero-Gimenez J, Wilbers R, Schots A, Williams C, Finnern R. Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system. Front Immunol. 2023;14:1088852.","journal-title":"Front Immunol"},{"key":"4656_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612963","author":"F Ruzzi","year":"2023","unstructured":"Ruzzi F, Semprini MS, Scalambra L, Palladini A, Angelicola S, Cappello C, et al. Virus-like particle (VLP) vaccines for cancer immunotherapy. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241612963.","journal-title":"Int J Mol Sci"},{"key":"4656_CR180","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-0716-3222-2_4","volume":"2671","author":"N Kobayashi","year":"2023","unstructured":"Kobayashi N, Arai R. Protein cages and nanostructures constructed from protein nanobuilding blocks. Methods Mol Biol. 2023;2671:79\u201394.","journal-title":"Methods Mol Biol"},{"issue":"8","key":"4656_CR181","doi-asserted-by":"publisher","first-page":"1807357","DOI":"10.1002\/adfm.201807357","volume":"29","author":"C Morris","year":"2019","unstructured":"Morris C, Glennie SJ, Lam HS, Baum HE, Kandage D, Williams NA, et al. A modular vaccine platform combining self-assembled peptide cages and immunogenic peptides. Adv Funct Mater. 2019;29(8):1807357.","journal-title":"Adv Funct Mater"},{"issue":"8","key":"4656_CR182","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1016\/j.apsb.2024.05.010","volume":"14","author":"X Peng","year":"2024","unstructured":"Peng X, Fang J, Lou C, Yang L, Shan S, Wang Z, et al. Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy. Acta Pharmaceutica Sinica B. 2024;14(8):3432\u201356.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"4656_CR183","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.molimm.2017.09.001","volume":"91","author":"S Ahmad","year":"2017","unstructured":"Ahmad S, Zamry AA, Tan H-TT, Wong KK, Lim J, Mohamud R. Targeting dendritic cells through gold nanoparticles: a review on the cellular uptake and subsequent immunological properties. Mol Immunol. 2017;91:123\u201333.","journal-title":"Mol Immunol"},{"key":"4656_CR184","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejpb.2023.09.012","volume":"192","author":"M Leroux","year":"2023","unstructured":"Leroux M, Benavides U, Hellel-Bourtal I, Silvarrey C, Milhau N, Marchal T, et al. Development of an oral nanovaccine for dogs against Echinococcus granulosus. Eur J Pharm Biopharm. 2023;192:185\u201395.","journal-title":"Eur J Pharm Biopharm"},{"key":"4656_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124404","volume":"661","author":"M Schlich","year":"2024","unstructured":"Schlich M, D\u2019Apice L, Lai F, Sinico C, Valenti D, Catalano F, et al. Boosting antigen-specific T cell activation with lipid-stabilized protein nanoaggregates. Int J Pharm. 2024;661:124404.","journal-title":"Int J Pharm"},{"key":"4656_CR186","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3389\/fimmu.2017.00319","volume":"8","author":"LN Adler","year":"2017","unstructured":"Adler LN, Jiang W, Bhamidipati K, Millican M, Macaubas C, Hung SC, et al. The other function: class II-restricted antigen presentation by B cells. Front Immunol. 2017;8:319.","journal-title":"Front Immunol"},{"issue":"1","key":"4656_CR187","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao T, Cai Y, Jiang Y, He X, Wei Y, Yu Y, et al. Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target Ther. 2023;8(1):283.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"4656_CR188","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1016\/j.apsb.2022.11.026","volume":"13","author":"W Zhang","year":"2023","unstructured":"Zhang W, Jiang Y, He Y, Boucetta H, Wu J, Chen Z, et al. Lipid carriers for mRNA delivery. Acta Pharm Sin B. 2023;13(10):4105\u201326.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"4656_CR189","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1021\/acsbiomaterials.6b00384","volume":"3","author":"E Dawson","year":"2017","unstructured":"Dawson E, Leleux JA, Pradhan P, Roy K. Surface-presentation of CpG and protein-antigen on pathogen-like polymer particles generate strong prophylactic and therapeutic antitumor protection. ACS Biomater Sci Eng. 2017;3(2):169\u201378.","journal-title":"ACS Biomater Sci Eng"},{"key":"4656_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13020193","author":"T Enya","year":"2025","unstructured":"Enya T, Ross SR. Innate sensing of viral nucleic acids and their use in antiviral vaccine development. Vaccines. 2025. https:\/\/doi.org\/10.3390\/vaccines13020193.","journal-title":"Vaccines"},{"issue":"3\u20134","key":"4656_CR191","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s44164-025-00096-5","volume":"4","author":"C Muzard","year":"2025","unstructured":"Muzard C, Seguin J, Bonnefoy J, Salkini N, Serra V, Alhareth K, et al. Pre-clinical evaluation of mRNA-lipid nanoparticles\u2019 potency and toxicity: current practices and future directions. In Vitro Model. 2025;4(3\u20134):177\u201394.","journal-title":"In Vitro Model"},{"issue":"5","key":"4656_CR192","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02303-y","volume":"23","author":"Y Takechi-Haraya","year":"2022","unstructured":"Takechi-Haraya Y, Ohgita T, Demizu Y, Saito H, Izutsu KI, Sakai-Kato K. Current status and challenges of analytical methods for evaluation of size and surface modification of nanoparticle-based drug formulations. AAPS PharmSciTech. 2022;23(5):150.","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"4656_CR193","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.7150\/thno.128136","volume":"16","author":"Y Chen","year":"2026","unstructured":"Chen Y, Zhang W, Huang X. Biomimetic cell membrane-coated nanovaccines in anti-tumor immunotherapy. Theranostics. 2026;16(9):5085\u2013104.","journal-title":"Theranostics"},{"key":"4656_CR194","doi-asserted-by":"crossref","unstructured":"Zhou H, Shi Y, Wang Y, Bai G. Exosome-based vaccines in cancer immunotherapy: antitumor mechanisms, engineering strategies, and challenges. J Cancer Res Clin Oncol. 2026;152(3).","DOI":"10.1007\/s00432-026-06435-7"},{"issue":"1","key":"4656_CR195","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1007\/s12672-025-02664-3","volume":"16","author":"MM Ammar","year":"2025","unstructured":"Ammar MM, Ali R, Abd Elaziz NA, Habib H, Abbas FM, Yassin MT, et al. Nanotechnology in oncology: advances in biosynthesis, drug delivery, and theranostics. Discov Oncol. 2025;16(1):1172.","journal-title":"Discov Oncol"},{"key":"4656_CR196","doi-asserted-by":"crossref","unstructured":"Pareek A, Kumar D, Pareek A, Gupta MM. Advancing cancer therapy with quantum dots and other nanostructures: a review of drug delivery innovations, applications, and challenges. Cancers (Basel). 2025;17(5).","DOI":"10.3390\/cancers17050878"},{"key":"4656_CR197","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-94-007-4543-8_11","volume-title":"Innovation in Vaccinology: from design, through to delivery and testing","author":"TG Kiros","year":"2012","unstructured":"Kiros TG, Levast B, Auray G, Strom S, van Kessel J, Gerdts V. The Importance of Animal Models in the Development of Vaccines. In: Baschieri S, editor. Innovation in Vaccinology: from design, through to delivery and testing. Dordrecht: Springer, Netherlands; 2012. p. 251\u201364."},{"key":"4656_CR198","doi-asserted-by":"crossref","unstructured":"Poppelaars F, Holers VM, Thurman JM. Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research. J Clin Invest. 2025;135(12).","DOI":"10.1172\/JCI188347"},{"key":"4656_CR199","doi-asserted-by":"crossref","unstructured":"Wei J, Li J, Li X, Du W, Su C, Sheng X, et al. The Impact of Animal Models and Strain Standardization on the Evaluation of Tuberculosis Vaccine Efficacy. Vaccines [Internet]. 2025; 13(7):[669 p.].","DOI":"10.3390\/vaccines13070669"},{"key":"4656_CR200","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1223260","volume":"14","author":"B Corleis","year":"2023","unstructured":"Corleis B, Bastian M, Hoffmann D, Beer M, Dorhoi A. Animal models for COVID-19 and tuberculosis. Front Immunol. 2023;14:1223260.","journal-title":"Front Immunol"},{"issue":"2","key":"4656_CR201","doi-asserted-by":"publisher","DOI":"10.1002\/pep2.70026","volume":"118","author":"P Jaishwal","year":"2026","unstructured":"Jaishwal P, Singh SP. Computational design of next-generation universal nanovaccine for COVID-19: a self-assembling coiled-coil platform approach. Pept Sci. 2026;118(2):e70026.","journal-title":"Pept Sci"},{"key":"4656_CR202","volume":"13","author":"HR Jahantigh","year":"2026","unstructured":"Jahantigh HR, Rezanavaz Gheshlagh S, Mafakher L, Ahmadi N, Shahbazi B, Ahmadi K. Advancing peptide-based vaccines against viral pathogens: a narrative review. Ther Adv Infect Dis. 2026;13:20499361251411188.","journal-title":"Ther Adv Infect Dis"},{"key":"4656_CR203","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2024.1405605","volume":"11","author":"AA Raji","year":"2024","unstructured":"Raji AA, Dastjerdi PZ, Omar AR. Virus-like particles in poultry disease: an approach to effective and safe vaccination. Front Vet Sci. 2024;11:1405605.","journal-title":"Front Vet Sci"},{"issue":"14","key":"4656_CR204","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119093119","volume":"119","author":"MH Teplensky","year":"2022","unstructured":"Teplensky MH, Distler ME, Kusmierz CD, Evangelopoulos M, Gula H, Elli D, et al. Spherical nucleic acids as an infectious disease vaccine platform. Proc Natl Acad Sci. 2022;119(14):e2119093119.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"4656_CR205","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1021\/ar500217w","volume":"47","author":"A Bansal","year":"2014","unstructured":"Bansal A, Zhang Y. Photocontrolled nanoparticle delivery systems for biomedical applications. Acc Chem Res. 2014;47(10):3052\u201360.","journal-title":"Acc Chem Res"},{"key":"4656_CR206","first-page":"373","volume-title":"Nanoparticles and antigen delivery: understanding the benefits and drawbacks of different delivery platforms","author":"NO Fischer","year":"2014","unstructured":"Fischer NO, Rasley A, Blanchette C. Nanoparticles and antigen delivery: understanding the benefits and drawbacks of different delivery platforms. Taylor & Francis; 2014. p. 373\u20136."},{"issue":"9","key":"4656_CR207","doi-asserted-by":"publisher","first-page":"2100402","DOI":"10.1002\/smtd.202100402","volume":"5","author":"C Rinoldi","year":"2021","unstructured":"Rinoldi C, Zargarian SS, Nakielski P, Li X, Liguori A, Petronella F, et al. Nanotechnology-assisted RNA delivery: from nucleic acid therapeutics to COVID-19 vaccines. Small Methods. 2021;5(9):2100402.","journal-title":"Small Methods"},{"issue":"11","key":"4656_CR208","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3390\/vaccines11111704","volume":"11","author":"SS Moni","year":"2023","unstructured":"Moni SS, Abdelwahab SI, Jabeen A, Elmobark ME, Aqaili D, Gohal G, et al. Advancements in vaccine adjuvants: the journey from alum to nano formulations. Vaccines. 2023;11(11):1704.","journal-title":"Vaccines"},{"issue":"51","key":"4656_CR209","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202303261","volume":"35","author":"Y Zong","year":"2023","unstructured":"Zong Y, Lin Y, Wei T, Cheng Q. Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy. Adv Mater. 2023;35(51):2303261.","journal-title":"Adv Mater"},{"issue":"3","key":"4656_CR210","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41578-021-00372-2","volume":"7","author":"GA Roth","year":"2022","unstructured":"Roth GA, Picece VC, Ou BS, Luo W, Pulendran B, Appel EA. Designing spatial and temporal control of vaccine responses. Nat Rev Mater. 2022;7(3):174\u201395.","journal-title":"Nat Rev Mater"},{"key":"4656_CR211","doi-asserted-by":"crossref","unstructured":"Karimi M, Zangabad PS, Mehdizadeh F, Malekzad H, Ghasemi A, Bahrami S, et al. Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger. Nanoscale. 2017;9(4):1356\u201392.","DOI":"10.1039\/C6NR07315H"},{"issue":"1","key":"4656_CR212","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2583553","volume":"14","author":"MA Moreno-Gonzalez","year":"2025","unstructured":"Moreno-Gonzalez MA, de Oliveira JFA, Penichet ML, Steinmetz NF. Virus nanoparticle intratumoral vaccines for HER2+ malignancies. OncoImmunology. 2025;14(1):2583553.","journal-title":"OncoImmunology"},{"key":"4656_CR213","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202524097","author":"BE Nachod","year":"2025","unstructured":"Nachod BE, Thatte AS, Palanki R, Mitchell MJ. Nanoparticle\u2010based tolerogenic vaccines: next\u2010generation strategies for autoimmune and allergic disease therapies. Angew Chem. 2025. https:\/\/doi.org\/10.1002\/ange.202524097.","journal-title":"Angew Chem"},{"issue":"1","key":"4656_CR214","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1021\/acsinfecdis.4c00771","volume":"11","author":"S Kumari","year":"2024","unstructured":"Kumari S, Martinez-Garcia J, Ehrman RN, Tang W, Miles J, Basak P, et al. Testing the antigenic potential of transmembrane proteins to develop a thermostable tuberculosis MOF-liposomal vaccine. ACS infectious diseases. 2024;11(1):204\u201315.","journal-title":"ACS infectious diseases"},{"key":"4656_CR215","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22091401","author":"L Palmerston Mendes","year":"2017","unstructured":"Palmerston Mendes L, Pan J, Torchilin VP. Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy. Molecules. 2017. https:\/\/doi.org\/10.3390\/molecules22091401.","journal-title":"Molecules"},{"issue":"9","key":"4656_CR216","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13090900","volume":"13","author":"J He","year":"2025","unstructured":"He J, Xiao W, Hua D, Liu M, Guo H, Xu L, et al. Nanovaccines: innovative advances from design strategies to clinical translation. Vaccines. 2025;13(9):900.","journal-title":"Vaccines"},{"issue":"39","key":"4656_CR217","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202501761","volume":"37","author":"R Davis Jr.","year":"2025","unstructured":"Davis R Jr., Duggal I, Peppas NA, Gaharwar AK. Designing the next generation of biomaterials through nanoengineering. Adv Mater. 2025;37(39):2501761.","journal-title":"Adv Mater"},{"issue":"7","key":"4656_CR218","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s44222-025-00306-5","volume":"3","author":"CA Mirkin","year":"2025","unstructured":"Mirkin CA, Mrksich M, Artzi N. The emerging era of structural nanomedicine. Nat Rev Bioeng. 2025;3(7):526\u20138.","journal-title":"Nat Rev Bioeng"},{"issue":"20","key":"4656_CR219","doi-asserted-by":"publisher","first-page":"18889","DOI":"10.1021\/acsnano.5c06380","volume":"19","author":"CA Mirkin","year":"2025","unstructured":"Mirkin CA, Langer R, Mrksich M, Margolin AA, Petrosko SH, Artzi N. Blueprints for better drugs: the structural revolution in nanomedicine. ACS Nano. 2025;19(20):18889\u2013901.","journal-title":"ACS Nano"},{"issue":"1","key":"4656_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3947\/ic.2022.0145","volume":"55","author":"JY Kim","year":"2023","unstructured":"Kim JY, Suh JW, Kang JS, Kim SB, Yoon YK, Sohn JW. Gram-negative bacteria\u2019s outer membrane vesicles. Infect Chemother. 2023;55(1):1\u20139.","journal-title":"Infect Chemother"},{"issue":"5","key":"4656_CR221","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.biotechadv.2017.05.003","volume":"35","author":"MJH Gerritzen","year":"2017","unstructured":"Gerritzen MJH, Martens DE, Wijffels RH, van der Pol L, Stork M. Bioengineering bacterial outer membrane vesicles as vaccine platform. Biotechnol Adv. 2017;35(5):565\u201374.","journal-title":"Biotechnol Adv"},{"issue":"1","key":"4656_CR222","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-024-13033-5","volume":"108","author":"EK Lei","year":"2024","unstructured":"Lei EK, Azmat A, Henry KA, Hussack G. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens. Appl Microbiol Biotechnol. 2024;108(1):232.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"4656_CR223","doi-asserted-by":"publisher","DOI":"10.1002\/asia.202500905","volume":"21","author":"X Li","year":"2026","unstructured":"Li X, Guo Z-X, Song C-L, Yang Y-W. A Viologen-based metal\u2013organic complex for highly efficient and selective dye flocculation. Chem Asian J. 2026;21(1):e00905.","journal-title":"Chem Asian J"},{"key":"4656_CR224","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24244605","author":"N Manousi","year":"2019","unstructured":"Manousi N, Giannakoudakis DA, Rosenberg E, Zachariadis GA. Extraction of metal ions with metal-organic frameworks. Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24244605.","journal-title":"Molecules"},{"key":"4656_CR225","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jconrel.2015.11.009","volume":"240","author":"KS Soni","year":"2016","unstructured":"Soni KS, Desale SS, Bronich TK. Nanogels: an overview of properties, biomedical applications and obstacles to clinical translation. J Control Release. 2016;240:109\u201326.","journal-title":"J Control Release"},{"key":"4656_CR226","doi-asserted-by":"publisher","DOI":"10.3390\/gels9090753","author":"PI Siafaka","year":"2023","unstructured":"Siafaka PI, Ozcan Bulbul E, Okur ME, Karantas ID, Ustundag Okur N. The application of nanogels as efficient drug delivery platforms for dermal\/transdermal delivery. Gels. 2023. https:\/\/doi.org\/10.3390\/gels9090753.","journal-title":"Gels"},{"key":"4656_CR227","doi-asserted-by":"crossref","unstructured":"Saggese A, Baccigalupi L, Donadio G, Ricca E, Isticato R. The Bacterial Spore as a Mucosal Vaccine Delivery System. Int J Mol Sci. 2023;24(13).","DOI":"10.3390\/ijms241310880"},{"issue":"4","key":"4656_CR228","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12997","volume":"28","author":"PM Katsande","year":"2023","unstructured":"Katsande PM, Nguyen VD, Nguyen TLP, Nguyen TKC, Mills G, Bailey DMD, et al. Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines. Helicobacter. 2023;28(4):e12997.","journal-title":"Helicobacter"},{"key":"4656_CR229","doi-asserted-by":"crossref","unstructured":"Priyanka, Abusalah MAH, Chopra H, Sharma A, Mustafa SA, Choudhary OP, et al. Nanovaccines: A game changing approach in the fight against infectious diseases. Biomedicine & Pharmacotherapy. 2023;167:115597.","DOI":"10.1016\/j.biopha.2023.115597"},{"key":"4656_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109887","volume":"117","author":"N Hashemi Goradel","year":"2023","unstructured":"Hashemi Goradel N, Nemati M, Bakhshandeh A, Arashkia A, Negahdari B. Nanovaccines for cancer immunotherapy: focusing on complex formation between adjuvant and antigen. Int Immunopharmacol. 2023;117:109887.","journal-title":"Int Immunopharmacol"},{"key":"4656_CR231","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2024.04.010","volume":"180","author":"EB Souto","year":"2024","unstructured":"Souto EB, Blanco-Llamero C, Krambeck K, Kiran NS, Yashaswini C, Postwala H, et al. Regulatory insights into nanomedicine and gene vaccine innovation: safety assessment, challenges, and regulatory perspectives. Acta Biomater. 2024;180:1\u201317.","journal-title":"Acta Biomater"},{"key":"4656_CR232","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/9798898810245125010009","volume-title":"Mucosal vaccine delivery systems: The future of immunization (Part 2)","author":"R Sharma","year":"2025","unstructured":"Sharma R, Dhamija K, Kumar S, Sharma S, Bhardwaj A. Bioprocessing and scale-up challenges in mucosal vaccine production. In: Mucosal vaccine delivery systems: The future of immunization (Part 2). Bentham Science Publishers; 2025. p. 173\u2013209."},{"issue":"33","key":"4656_CR233","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303567120","volume":"120","author":"SJ Shepherd","year":"2023","unstructured":"Shepherd SJ, Han X, Mukalel AJ, El-Mayta R, Thatte AS, Wu J, et al. Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines. Proc Natl Acad Sci. 2023;120(33):e2303567120.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"4656_CR234","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.1021\/acsomega.3c08353","volume":"9","author":"X Zhang","year":"2024","unstructured":"Zhang X, Li Y, Zhou Z. Lipid nanoparticle-based delivery system-a competing place for mRNA vaccines. ACS Omega. 2024;9(6):6219\u201334.","journal-title":"ACS Omega"},{"key":"4656_CR235","doi-asserted-by":"crossref","unstructured":"Wang J, Ding Y, Chong K, Cui M, Cao Z, Tang C, et al. Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery. Vaccines (Basel). 2024;12(10).","DOI":"10.3390\/vaccines12101148"},{"issue":"39","key":"4656_CR236","doi-asserted-by":"publisher","first-page":"32572","DOI":"10.1039\/D5RA01788B","volume":"15","author":"A Harini","year":"2025","unstructured":"Harini A, Perumal I. Polymeric nanomaterials as a drug delivery system for anticancer and antibacterial infections: a review. RSC Adv. 2025;15(39):32572\u201392.","journal-title":"RSC Adv"},{"key":"4656_CR237","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2026.1735885","volume":"14","author":"F Stucchi","year":"2026","unstructured":"Stucchi F, Li M, Castellano G, Cellesi F. Regulatory framework for polymer-based nanotherapeutics in clinical translation. Front Bioeng Biotechnol. 2026;14:1735885.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"4656_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-023-03943-0","volume":"18","author":"G Unnikrishnan","year":"2023","unstructured":"Unnikrishnan G, Joy A, Megha M, Kolanthai E, Senthilkumar M. Exploration of inorganic nanoparticles for revolutionary drug delivery applications: a critical review. Discov Nano. 2023;18(1):157.","journal-title":"Discov Nano"},{"key":"4656_CR239","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010043","author":"R Riyazuddin","year":"2021","unstructured":"Riyazuddin R, Nisha N, Ejaz B, Khan MIR, Kumar M, Ramteke PW, et al. A comprehensive review on the heavy metal toxicity and sequestration in plants. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom12010043.","journal-title":"Biomolecules"},{"key":"4656_CR240","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1001572","volume":"10","author":"N Zhang","year":"2022","unstructured":"Zhang N, Xiong G, Liu Z. Toxicity of metal-based nanoparticles: challenges in the nano era. Front Bioeng Biotechnol. 2022;10:1001572.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"4656_CR241","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4161\/hv.22218","volume":"9","author":"Q Chen","year":"2013","unstructured":"Chen Q, Lai H. Plant-derived virus-like particles as vaccines. Hum Vaccin Immunother. 2013;9(1):26\u201349.","journal-title":"Hum Vaccin Immunother"},{"key":"4656_CR242","doi-asserted-by":"publisher","DOI":"10.3390\/biomimetics11020150","author":"ME Barbinta-Patrascu","year":"2026","unstructured":"Barbinta-Patrascu ME, Negut I, Bita B. Virus biomimetic-delivery systems for the production of vaccines. Biomimetics (Basel). 2026. https:\/\/doi.org\/10.3390\/biomimetics11020150.","journal-title":"Biomimetics (Basel)"},{"key":"4656_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxnano.2025.100223","volume":"8","author":"A Vignesh","year":"2025","unstructured":"Vignesh A, Menaka C, Amal TC, Selvakumar S, Vasanth K. Exploring the dual impact of nanoparticles on human well-being: a comprehensive review of risks and benefits. Next Nanotechnology. 2025;8:100223.","journal-title":"Next Nanotechnology"},{"issue":"11","key":"4656_CR244","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112463","volume":"14","author":"A Ahmad","year":"2022","unstructured":"Ahmad A, Imran M, Sharma N. Precision nanotoxicology in drug development: current trends and challenges in safety and toxicity implications of customized multifunctional nanocarriers for drug-delivery applications. Pharmaceutics. 2022;14(11):2463.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4656_CR245","doi-asserted-by":"publisher","DOI":"10.1080\/29947677.2024.2443439","volume":"1","author":"GY Scott","year":"2025","unstructured":"Scott GY, Aborode AT, Adesola RO, Khan M, Elebesunu EE, Oluwaseun AA, et al. Enhancing vaccine quality and accessibility: strategies for efficient storage and distribution in resource-constrained environment. Outbreak Manag Response. 2025;1(1):2443439.","journal-title":"Outbreak Manag Response"},{"key":"4656_CR246","doi-asserted-by":"crossref","unstructured":"Mahaling B, Baruah N, Manthripragada P, Dinabandhu A. Chapter 24 - Safety assessment for nanomedicines and nanovaccines. In: Nguyen TA, Prajapati BG, Kapoor DU, editors. Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments: Academic Press; 2026. p. 411\u201342.","DOI":"10.1016\/B978-0-443-44579-8.00002-3"},{"key":"4656_CR247","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114076","author":"H Choi","year":"2025","unstructured":"Choi H, Son S. Emerging nano-vaccine technologies to overcome anti-microbial resistance. J Control Release. 2025. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114076.","journal-title":"J Control Release"},{"issue":"5","key":"4656_CR248","first-page":"227","volume":"9","author":"M-G Kim","year":"2014","unstructured":"Kim M-G, Park JY, Shon Y, Kim G, Shim G, Oh Y-K. Nanotechnology and vaccine development. Asian J Pharm Sci. 2014;9(5):227\u201335.","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"4656_CR249","doi-asserted-by":"publisher","first-page":"2518636","DOI":"10.1080\/21645515.2025.2518636","volume":"21","author":"T Sommers","year":"2025","unstructured":"Sommers T, Dockery M, Burke N, D\u2019Souza S, Troupe B, Agbonyinma T, et al. Building trust and equity in vaccine communication through community engagement. Hum Vaccin Immunother. 2025;21(1):2518636.","journal-title":"Hum Vaccin Immunother"},{"key":"4656_CR250","doi-asserted-by":"publisher","DOI":"10.3390\/mi16040419","author":"N Parvin","year":"2025","unstructured":"Parvin N, Joo SW, Jung JH, Mandal TK. Innovative micro- and nano-architectures in biomedical engineering for therapeutic and diagnostic applications. Micromachines. 2025. https:\/\/doi.org\/10.3390\/mi16040419.","journal-title":"Micromachines"},{"issue":"1","key":"4656_CR251","first-page":"54","volume":"32","author":"R Patel","year":"2023","unstructured":"Patel R, Patel A. Overcoming challenges in vaccine development: immunogenicity, safety, and large-scale manufacturing. Well Test J. 2023;32(1):54\u201375.","journal-title":"Well Test J"},{"issue":"29","key":"4656_CR252","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202502315","volume":"21","author":"N Desai","year":"2025","unstructured":"Desai N, Rana D, Patel M, Bajwa N, Prasad R, Vora LK. Nanoparticle therapeutics in clinical perspective: classification, marketed products, and regulatory landscape. Small. 2025;21(29):e2502315.","journal-title":"Small"},{"key":"4656_CR253","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13050473","author":"JH Skerritt","year":"2025","unstructured":"Skerritt JH. Considerations for mRNA product development, regulation and deployment across the lifecycle. Vaccines. 2025. https:\/\/doi.org\/10.3390\/vaccines13050473.","journal-title":"Vaccines"},{"key":"4656_CR254","unstructured":"Ferrari D. Pre-clinical assessment of the therapeutic efficacy of a nanovaccine in a mouse model of pancreatic cancer. 2024."},{"issue":"7","key":"4656_CR255","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071438","volume":"14","author":"DA Dri","year":"2022","unstructured":"Dri DA, Gaucci E, Torrieri I, Carafa M, Marianecci C, Gramaglia D. Critical analysis and quality assessment of nanomedicines and nanocarriers in clinical trials: three years of activity at the clinical trials office. Pharmaceutics. 2022;14(7):1438.","journal-title":"Pharmaceutics"},{"key":"4656_CR256","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1544393","volume":"12","author":"FD Rodr\u00edguez-G\u00f3mez","year":"2025","unstructured":"Rodr\u00edguez-G\u00f3mez FD, Monferrer D, Penon O, Rivera-Gil P. Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks. Front Med (Lausanne). 2025;12:1544393.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"4656_CR257","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1021\/acsomega.9b00128","volume":"4","author":"A Bokare","year":"2019","unstructured":"Bokare A, Takami A, Kim JH, Dong A, Chen A, Valerio R, et al. Herringbone-patterned 3D-printed devices as alternatives to microfluidics for reproducible production of lipid polymer hybrid nanoparticles. ACS Omega. 2019;4(3):4650\u20137.","journal-title":"ACS Omega"},{"issue":"4","key":"4656_CR258","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1021\/acs.accounts.4c00738","volume":"58","author":"X Li","year":"2025","unstructured":"Li X, Qin Z, Wang S, Zhang L, Jiang X. Microfluidics-assembled nanovesicles for nucleic acid delivery. Acc Chem Res. 2025;58(4):570\u201382.","journal-title":"Acc Chem Res"},{"issue":"44","key":"4656_CR259","doi-asserted-by":"publisher","first-page":"59777","DOI":"10.1021\/acsami.4c11366","volume":"16","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang Y, Peng F, Li C, Wang Q, Wang Z, et al. Macrophage membrane-coated nanoparticles for the delivery of Natamycin exhibit increased antifungal and anti-inflammatory activities in fungal keratitis. ACS Appl Mater Interfaces. 2024;16(44):59777\u201388.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"24","key":"4656_CR260","doi-asserted-by":"publisher","first-page":"20399","DOI":"10.1021\/acsami.7b02900","volume":"9","author":"X Mu","year":"2017","unstructured":"Mu X, Wang JY, Bai X, Xu F, Liu H, Yang J, et al. Black phosphorus quantum dot induced oxidative stress and toxicity in living cells and mice. ACS Appl Mater Interfaces. 2017;9(24):20399\u2013409.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"4656_CR261","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102628","volume":"36","author":"P Garcia-Valtanen","year":"2025","unstructured":"Garcia-Valtanen P, Yeow AEL, Mekonnen ZA, Whelan DM, Santos R, Al-Delfi Z, et al. Thermostable unit solid dose formulations for subcutaneous administration of DNA vaccines. Mol Ther Nucleic Acids. 2025;36(3):102628.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4656_CR262","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127684","volume":"64","author":"LI Mayerlen","year":"2025","unstructured":"Mayerlen LI, Wong TAS, To A, Smith O, Chuang E, Donini O, et al. Thermostable bivalent & trivalent filovirus vaccines from insect cells: potency demonstrated after 3 months and 2 years. Vaccine. 2025;64:127684.","journal-title":"Vaccine"},{"issue":"1","key":"4656_CR263","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2022.2147286","volume":"11","author":"SK Niazi","year":"2023","unstructured":"Niazi SK, Al-Shaqha WM, Mirza Z. Proposal of international council for harmonization (ICH) guideline for the approval of biosimilars. J Mark Access Health Policy. 2023;11(1):2147286.","journal-title":"J Mark Access Health Policy"},{"issue":"2","key":"4656_CR264","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2024.102648","volume":"18","author":"C Cagnotta","year":"2025","unstructured":"Cagnotta C, Lettera N, Cardillo M, Pirozzi D, Catalan-Matamoros D, Capuano A, et al. Parental vaccine hesitancy: Recent evidences support the need to implement targeted communication strategies. J Infect Public Health. 2025;18(2):102648.","journal-title":"J Infect Public Health"},{"key":"4656_CR265","doi-asserted-by":"crossref","unstructured":"Kaushik A, Fomicheva J, Boonstra N, Faber E, Gupta S, Kest H. Pediatric vaccine hesitancy in the united states-the growing problem and strategies for management including motivational interviewing. Vaccines (Basel). 2025;13(2).","DOI":"10.3390\/vaccines13020115"},{"issue":"4","key":"4656_CR266","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12668-026-02476-x","volume":"16","author":"NI Okafor","year":"2026","unstructured":"Okafor NI, Igbokwe N, Onohuean H, Faya M, Choonara YE. Artificial intelligence-driven development and characterization of nanomedicine. BioNanoScience. 2026;16(4):255.","journal-title":"BioNanoScience"},{"issue":"1","key":"4656_CR267","doi-asserted-by":"publisher","first-page":"29","DOI":"10.6026\/973206300200029","volume":"20","author":"R Farzan","year":"2024","unstructured":"Farzan R. Artificial intelligence in Immuno-genetics. Bioinformation. 2024;20(1):29\u201335.","journal-title":"Bioinformation"},{"key":"4656_CR268","doi-asserted-by":"crossref","unstructured":"Elfatimi E, Lekbach Y, Prakash S, BenMohamed L. Artificial intelligence and machine learning in the development of vaccines and immunotherapeutics\u2014yesterday, today, and tomorrow. Frontiers in Artificial Intelligence. 2025 Volume 8 - 2025.","DOI":"10.3389\/frai.2025.1620572"},{"key":"4656_CR269","doi-asserted-by":"publisher","first-page":"1620572","DOI":"10.3389\/frai.2025.1620572","volume":"8","author":"E Elfatimi","year":"2025","unstructured":"Elfatimi E, Lekbach Y, Prakash S, BenMohamed L. Artificial intelligence and machine learning in the development of vaccines and immunotherapeutics-yesterday, today, and tomorrow. Front Artif Intell. 2025;8:1620572.","journal-title":"Front Artif Intell"},{"key":"4656_CR270","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2025.102786","volume":"44","author":"A Hariri","year":"2025","unstructured":"Hariri A, Mirian M, Zarepour A, Khosravi A, Iravani S, Zarrabi A. Lipid nanoparticles driving mRNA vaccine innovations: from concept to clinic. Appl Mater Today. 2025;44:102786.","journal-title":"Appl Mater Today"},{"issue":"2","key":"4656_CR271","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.apsb.2025.11.029","volume":"16","author":"K Su","year":"2026","unstructured":"Su K, Qiu J, Xu T, Liu S. Artificial intelligence-guided design of lipid nanoparticles for mRNA delivery. Acta Pharm Sin B. 2026;16(2):709\u201327.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"4656_CR272","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.apsb.2025.12.011","volume":"16","author":"C Shen","year":"2026","unstructured":"Shen C, Zhang M, Lu M, Chang E, Gao Z, Ban W, et al. Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: current applications, challenges, and future perspectives. Acta Pharmaceutica Sinica B. 2026;16(2):665\u201385.","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"2","key":"4656_CR273","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.apsb.2025.12.011","volume":"16","author":"C Shen","year":"2026","unstructured":"Shen C, Zhang M, Lu M, Chang E, Gao Z, Ban W, et al. Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: current applications, challenges, and future perspectives. Acta Pharm Sin B. 2026;16(2):665\u201385.","journal-title":"Acta Pharm Sin B"},{"key":"4656_CR274","doi-asserted-by":"publisher","first-page":"1567116","DOI":"10.3389\/fimmu.2025.1567116","volume":"16","author":"RA El Arab","year":"2025","unstructured":"El Arab RA, Alkhunaizi M, Alhashem YN, Al Khatib A, Bubsheet M, Hassanein S. Artificial intelligence in vaccine research and development: an umbrella review. Front Immunol. 2025;16:1567116.","journal-title":"Front Immunol"},{"key":"4656_CR275","doi-asserted-by":"publisher","first-page":"1723110","DOI":"10.3389\/fimmu.2025.1723110","volume":"16","author":"S Tourdot","year":"2025","unstructured":"Tourdot S, Karle AC, Rosenbaum M, Ackaert C, Le Vu P, Gutknecht M, et al. T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform. Front Immunol. 2025;16:1723110.","journal-title":"Front Immunol"},{"key":"4656_CR276","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1357217","volume":"15","author":"A Kumar","year":"2024","unstructured":"Kumar A, Dixit S, Srinivasan K, M D, Vincent P. Personalized cancer vaccine design using AI-powered technologies. Front Immunol. 2024;15:1357217.","journal-title":"Front Immunol"},{"key":"4656_CR277","doi-asserted-by":"publisher","DOI":"10.3390\/nano15120895","author":"N Parvin","year":"2025","unstructured":"Parvin N, Joo SW, Jung JH, Mandal TK. Multimodal AI in biomedicine: pioneering the future of biomaterials, diagnostics, and personalized healthcare. Nanomaterials. 2025. https:\/\/doi.org\/10.3390\/nano15120895.","journal-title":"Nanomaterials"},{"key":"4656_CR278","doi-asserted-by":"publisher","DOI":"10.3390\/ph18010047","author":"F Mirakhori","year":"2025","unstructured":"Mirakhori F, Niazi SK. Harnessing the AI\/ML in drug and biological products discovery and development: the regulatory perspective. Pharmaceuticals (Basel). 2025. https:\/\/doi.org\/10.3390\/ph18010047.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4656_CR279","doi-asserted-by":"publisher","first-page":"175628482513219","DOI":"10.1177\/17562848251321915","volume":"18","author":"R Sedano","year":"2025","unstructured":"Sedano R, Solitano V, Vuyyuru SK, Yuan Y, Hanzel J, Ma C, et al. Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review. Therap Adv Gastroenterol. 2025;18:17562848251321916.","journal-title":"Therap Adv Gastroenterol"},{"key":"4656_CR280","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16101328","author":"DR Serrano","year":"2024","unstructured":"Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, et al. Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16101328.","journal-title":"Pharmaceutics"},{"issue":"17","key":"4656_CR281","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1039\/D3TB02861E","volume":"12","author":"Y Cui","year":"2024","unstructured":"Cui Y, Ho M, Hu Y, Shi Y. Vaccine adjuvants: current status, research and development, licensing, and future opportunities. J Mater Chem B. 2024;12(17):4118\u201337.","journal-title":"J Mater Chem B"},{"issue":"1","key":"4656_CR282","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-024-00222-x","volume":"5","author":"IN Weerarathna","year":"2024","unstructured":"Weerarathna IN, Doelakeh ES, Kiwanuka L, Kumar P, Arora S. Prophylactic and therapeutic vaccine development: advancements and challenges. Mol Biomed. 2024;5(1):57.","journal-title":"Mol Biomed"},{"key":"4656_CR283","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11020146","author":"SNH Bukhari","year":"2022","unstructured":"Bukhari SNH, Jain A, Haq E, Mehbodniya A, Webber J. Machine learning techniques for the prediction of B-Cell and T-Cell epitopes as potential vaccine targets with a specific focus on SARS-CoV-2 pathogen: a review. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens11020146.","journal-title":"Pathogens"},{"issue":"1","key":"4656_CR284","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81749-9","volume":"11","author":"Z Yang","year":"2021","unstructured":"Yang Z, Bogdan P, Nazarian S. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study. Sci Rep. 2021;11(1):3238.","journal-title":"Sci Rep"},{"key":"4656_CR285","doi-asserted-by":"publisher","DOI":"10.3390\/nano15171354","author":"A Abughalia","year":"2025","unstructured":"Abughalia A, Flynn M, Clarke PFA, Fayne D, Gobbo OL. The use of computational approaches to design nanodelivery systems. Nanomaterials (Basel). 2025. https:\/\/doi.org\/10.3390\/nano15171354.","journal-title":"Nanomaterials (Basel)"},{"key":"4656_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122158","volume":"299","author":"Y Qin","year":"2023","unstructured":"Qin Y, Walters AA, Rouatbi N, Wang JT, Abdel-Bar HM, Al-Jamal KT. Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery. Biomaterials. 2023;299:122158.","journal-title":"Biomaterials"},{"key":"4656_CR287","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13040420","author":"L Montgomery","year":"2025","unstructured":"Montgomery L, Larbi A. Monitoring immune responses to vaccination: a focus on single-cell analysis and associated challenges. Vaccines. 2025. https:\/\/doi.org\/10.3390\/vaccines13040420.","journal-title":"Vaccines"},{"key":"4656_CR288","doi-asserted-by":"publisher","first-page":"1217206","DOI":"10.3389\/fimmu.2023.1217206","volume":"14","author":"Y Takemoto","year":"2023","unstructured":"Takemoto Y, Tanimine N, Yoshinaka H, Tanaka Y, Takafuta T, Sugiyama A, et al. Multi-phasic gene profiling using candidate gene approach predict the capacity of specific antibody production and maintenance following COVID-19 vaccination in Japanese population. Front Immunol. 2023;14:1217206.","journal-title":"Front Immunol"},{"key":"4656_CR289","first-page":"101","volume":"179","author":"J Aranda Hernandez","year":"2022","unstructured":"Aranda Hernandez J, Heuer C, Bahnemann J, Szita N. Microfluidic devices as process development tools for cellular therapy manufacturing. Adv Biochem Eng Biotechnol. 2022;179:101\u201327.","journal-title":"Adv Biochem Eng Biotechnol"},{"issue":"8","key":"4656_CR290","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1039\/D2LC00025C","volume":"22","author":"R Salahandish","year":"2022","unstructured":"Salahandish R, Hassani M, Zare A, Haghayegh F, Sanati-Nezhad A. Autonomous electrochemical biosensing of glial fibrillary acidic protein for point-of-care detection of central nervous system injuries. Lab Chip. 2022;22(8):1542\u201355.","journal-title":"Lab Chip"},{"issue":"3","key":"4656_CR291","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1021\/acs.nanolett.0c03646","volume":"21","author":"Z Meng","year":"2021","unstructured":"Meng Z, Zhang Y, She J, Zhou X, Xu J, Han X, et al. Ultrasound-mediated remotely controlled nanovaccine delivery for tumor vaccination and individualized cancer immunotherapy. Nano Lett. 2021;21(3):1228\u201337.","journal-title":"Nano Lett"},{"issue":"12","key":"4656_CR292","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41565-020-00781-4","volume":"15","author":"J Xu","year":"2020","unstructured":"Xu J, Lv J, Zhuang Q, Yang Z, Cao Z, Xu L, et al. A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy. Nat Nanotechnol. 2020;15(12):1043\u201352.","journal-title":"Nat Nanotechnol"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04656-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04656-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04656-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:02:04Z","timestamp":1784102524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04656-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":292,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4656"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04656-w","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"344"}}